clinicalAssessmentToolId,assessmentName,assessmentType,targetPopulation,diseaseSpecific,numberOfItems,scoringMethod,validatedLanguages,psychometricProperties,administrationTime,availabilityStatus,licensingRequirements,digitalVersion,_pmid,_doi,_publicationTitle,_foundIn,_confidence,_contextSnippet,_whyMissed,_reasoning,_source,_completenessScore,_criticalFieldsScore,_missingCriticalFields,_hasMinimumFields
ec715aaf-c67e-48dd-baa3-e93796e717d0,American College of Medical Genetics and Genomics (ACMG) 2015 guideline,,,,,,,,,,,,PMID:18218617,,"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.",results,0.8,All the P/LP variants were classified based on American College of Medical Genetics and Genomics (ACMG) 2015 guideline,Clinical guideline/classification system not recognized as assessment tool,,AI validation - Sonnet 4.5,0,0,,
460856ba-ff33-4fc3-8978-df0c7ca396e3,Rey complex figure test,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.95,"Primary outcomes were scores on a Rey complex figure test (delayed recall), cancellation test (speed), prism adaptation, and the mean brain apparent diffusion coefficient",This is a well-established neuropsychological test used to assess visuospatial constructional ability and visual memory. It was used as a primary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
40e66a06-f5be-469c-b3b0-eef4bdccbbb7,cancellation test,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.9,"Primary outcomes were scores on a Rey complex figure test (delayed recall), cancellation test (speed), prism adaptation",This is a standardized neuropsychological test used to assess attention and processing speed. It was used as a primary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
a039fef1-3e01-4db7-bdf1-14b3996f51c1,prism adaptation,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.85,"Primary outcomes were scores on a Rey complex figure test (delayed recall), cancellation test (speed), prism adaptation, and the mean brain apparent diffusion coefficient",This is a neuropsychological assessment technique used to evaluate visuospatial attention and adaptation. It was used as a primary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
de73dbdf-bbd1-424c-97b5-476c8cfa0f5a,Stroop color word test,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.95,"Secondary outcome measures were scores on the cancellation test (standard deviation), Stroop color word test, block design, object assembly",This is a well-established neuropsychological test used to assess cognitive flexibility and executive function. It was used as a secondary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
214d2780-ffe4-43ad-9318-eacaaa22b6b1,block design,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.9,"Secondary outcome measures were scores on the cancellation test (standard deviation), Stroop color word test, block design, object assembly",This is a standardized subtest (typically from WISC or WAIS) used to assess visuospatial processing and nonverbal reasoning. It was used as a secondary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
88ecc532-f2e3-4e81-993e-ce3e0947ad61,object assembly,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.9,"Secondary outcome measures were scores on the cancellation test (standard deviation), Stroop color word test, block design, object assembly, Rey complex figure test (copy)",This is a standardized subtest used to assess visuospatial processing and perceptual organization. It was used as a secondary outcome measure and showed significant improvement.,,AI validation - Sonnet 4.5,0,0,,
0b94bf49-618b-469e-8fc8-e50410b67c18,Beery developmental test of visual-motor integration,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.95,"Rey complex figure test (copy), Beery developmental test of visual-motor integration, and judgment of line orientation",This is a standardized developmental assessment tool (VMI) used to evaluate visual-motor integration skills in children. It was used as a secondary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
30540877-70af-4b69-9c8a-457141eda306,judgment of line orientation,,,,,,,,,,,,PMID:18632543,,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,abstract,0.9,"Beery developmental test of visual-motor integration, and judgment of line orientation. Scores were corrected for baseline performance, age, and sex.",This is a standardized neuropsychological test used to assess visuospatial perception and judgment. It was used as a secondary outcome measure.,,AI validation - Sonnet 4.5,0,0,,
c63e4436-30aa-437b-b9b8-7c69da932d38,word recognition scores using 50-word recorded lists,,,,,,,,,,,,PMID:19430883,,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,abstract,0.8,Hearing response is defined as a statistically significant improvement in word recognition scores using 50-word recorded lists in audiology.,This is a specific audiological assessment method/protocol that constitutes a clinical assessment tool for hearing evaluation in NF2 patients. Current mining patterns may not capture detailed assessment methodologies described within response criteria definitions.,,AI validation - Sonnet 4.5,0,0,,
9ad27b03-bd3d-485d-98b6-5c1056ddf0ad,NF-1Score,,,,,,,,,,,,PMID:20428190,,NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1.,abstract,0.9,Our purpose was to develop and to validate a clinical score for predicting internal neurofibromas in adults...The score computed by linear combination of the rounded coefficients of these four variables ranged from 0 to 40,"The prediction score developed in this study is itself a clinical assessment tool, but may not have been recognized as such by mining patterns",,AI validation - Sonnet 4.5,0,0,,
cf83ef75-e9e5-4720-a572-10888ab496e3,working memory assays,,,,,,,,,,,,PMID:20624961,,Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.,abstract,0.8,"...Accordingly, working memory assays applied during functional MRI (fMRI) studies in human subjects...",Specific assessment tools used to measure cognitive function in human subjects,,AI validation - Sonnet 4.5,0,0,,
2f32b0b5-0680-4aa0-b236-302d2eade57f,behavioral working memory probes,,,,,,,,,,,,PMID:20624961,,Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.,abstract,0.75,"...Here, we use behavioral working memory probes and electrophysiological studies in a mouse model...",Behavioral assessment tools used for cognitive testing in mice,,AI validation - Sonnet 4.5,0,0,,
decc4698-52b4-4619-86ef-76e60256405a,Rotarod,,,,,,,,,,,,PMID:21352477,,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,abstract,0.9,"...Using the Rotarod, a non-specific motor performance test, we confirmed that, like NF1 patients, Nf1(+/-) mice have motor deficits...","Behavioral testing apparatus for motor performance assessment, commonly used in neuroscience research",,AI validation - Sonnet 4.5,0,0,,
69195153-a94c-4b48-b055-25fcf5073b80,Erasmus ladder,,,,,,,,,,,,PMID:21352477,,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,abstract,0.85,"...Nf1(+/-) mice showed no impairment on the Erasmus ladder, as step time and number of missteps were not different...","Specific behavioral testing apparatus for motor coordination assessment, should be detected by assessment tool patterns",,AI validation - Sonnet 4.5,0,0,,
74d4049f-34de-4984-803a-984c7e718c73,optokinetic reflex,,,,,,,,,,,,PMID:21352477,,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,abstract,0.8,"...when compensatory eye movements were tested, no performance deficits were found in the optokinetic reflex and vestibulo-ocular reflex...",Physiological assessment protocol for testing visual-motor reflexes,,AI validation - Sonnet 4.5,0,0,,
12f8c3b7-0113-4074-8792-2f884133f632,vestibulo-ocular reflex,,,,,,,,,,,,PMID:21352477,,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,abstract,0.8,...no performance deficits were found in the optokinetic reflex and vestibulo-ocular reflex in the dark (VOR) or in the light (VVOR)...,"Physiological assessment protocol for testing vestibular-motor reflexes, includes VOR and VVOR variants",,AI validation - Sonnet 4.5,0,0,,
5aa23c74-3598-4021-a3c7-8e52050d72e7,VOR adaptation paradigms,,,,,,,,,,,,PMID:21352477,,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,abstract,0.75,"...Nf1(+/-) mice successfully completed short- and long-term VOR adaptation paradigms, tests that both depend on cerebellar function...",Specific behavioral testing protocols for cerebellar function assessment,,AI validation - Sonnet 4.5,0,0,,
b2f3c4a1-cb4d-4cbb-9493-aad1b3d811f4,NIH criteria,,,,,,,,,,,,PMID:21963267,,Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.,abstract,0.9,"...95 consecutive adult and pediatric patients (190 eyes) with NF1, diagnosed based on the National Institutes of Health (NIH) criteria. Controls included 100 healthy age- and gender-matched control subjects...",Standard diagnostic criteria are clinical assessment tools but may not have been recognized by mining patterns focused on questionnaires/scales,,AI validation - Sonnet 4.5,0,0,,
00b3e675-1d43-4240-a1f2-462bc83be30e,Confocal scanning laser ophthalmoscopy,,,,,,,,,,,,PMID:21963267,,Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.,abstract,0.85,"...METHODS: Confocal scanning laser ophthalmoscopy was performed for each subject, investigating the presence and the number of choroidal abnormalities...",Imaging-based diagnostic technique may not have been captured by patterns focused on questionnaires rather than diagnostic imaging methods,,AI validation - Sonnet 4.5,0,0,,
abf9201c-1ab4-416e-8b88-ab5ba7614481,PedsQL™ NF1 Module,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",abstract,0.98,"The objective of this study was to develop an NF1 HRQOL instrument as a module of PedsQL™ and to test for its initial feasibility, internal consistency reliability and validity in adults with NF1.",This is the primary clinical assessment tool being developed in this study - a validated questionnaire for measuring health-related quality of life in NF1 patients,,AI validation - Sonnet 4.5,0,0,,
c343bfdb-cc44-47ca-8800-9a77fcf41564,PedsQL™ 4.0 Generic Core Scales,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",methods,0.85,"The NF1 HRQOL format, instructions, and Likert response scale are similar to the PedsQL™ 4.0 Generic Core Scales and other PedsQL™ Disease-Specific Modules.",Referenced as an established clinical assessment tool used as a template for the new NF1 module,,AI validation - Sonnet 4.5,0,0,,
0b837630-c79e-448f-be24-807b44a058de,PedsQL™ Arthritis Module,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",methods,0.8,"Pertinent questions were drawn from the existing PedsQL™ Arthritis, Cancer, Cerebral Palsy and Family Impact Modules",Existing validated clinical assessment tool used as source material for developing the NF1 module,,AI validation - Sonnet 4.5,0,0,,
4297324b-d33c-49aa-9d93-6c3b1b9d7f2d,PedsQL™ Cancer Module,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",methods,0.8,"Pertinent questions were drawn from the existing PedsQL™ Arthritis, Cancer, Cerebral Palsy and Family Impact Modules",Existing validated clinical assessment tool used as source material for developing the NF1 module,,AI validation - Sonnet 4.5,0,0,,
acbeadf1-1b91-4a4f-8754-1ab797b71af4,PedsQL™ Cerebral Palsy Module,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",methods,0.8,"Pertinent questions were drawn from the existing PedsQL™ Arthritis, Cancer, Cerebral Palsy and Family Impact Modules",Existing validated clinical assessment tool used as source material for developing the NF1 module,,AI validation - Sonnet 4.5,0,0,,
e0431454-e99d-4821-86e3-ac8d6e839e29,PedsQL™ Family Impact Module,,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",methods,0.8,"Pertinent questions were drawn from the existing PedsQL™ Arthritis, Cancer, Cerebral Palsy and Family Impact Modules",Existing validated clinical assessment tool used as source material for developing the NF1 module,,AI validation - Sonnet 4.5,0,0,,
bdeeca04-5253-4fec-a8d5-adec6f401ac6,Short Form 36 health survey (SF-36),,,,,,,,,,,,PMID:23432799,,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",introduction,0.9,Studies of generic instruments showed that NF1 had a significant impact on all domains of the Short Form 36 health survey (SF-36) when compared to the normative population,Well-established clinical assessment tool referenced for comparison and validation purposes,,AI validation - Sonnet 4.5,0,0,,
7dc0f3dc-0727-44fa-80b7-b4a8cc4a9cda,Teller acuity cards,,,,,,,,,,,,PMID:24249802,,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,abstract,0.95,...Visual acuity (VA) assessments using consistent quantitative testing methods are recommended as the main functional outcome measure for NF1-OPG clinical trials. Teller acuity cards are recommended for use as the primary VA endpoint...,This is a specific visual acuity assessment tool recommended as the primary endpoint for clinical trials. It's a standardized clinical assessment instrument.,,AI validation - Sonnet 4.5,0,0,,
9cf56680-0ff0-4f14-8b18-5f85c8ece0d3,HOTV,,,,,,,,,,,,PMID:24249802,,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,abstract,0.9,"...Teller acuity cards are recommended for use as the primary VA endpoint, and HOTV as a secondary endpoint once subjects are old enough to complete it...",HOTV is a specific visual acuity test used as a secondary endpoint. It's a standardized clinical assessment tool for measuring visual acuity in children.,,AI validation - Sonnet 4.5,0,0,,
89c71a47-946d-4f68-a344-57b6c2a54009,Children's Visual Function Questionnaire,,,,,,,,,,,,PMID:24249802,,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,abstract,0.95,"...Given the importance of capturing patient-reported outcomes in clinical trials, evaluating visual quality of life using the Children's Visual Function Questionnaire as a secondary endpoint is also proposed...",This is a validated quality of life questionnaire specifically designed to assess visual function in children. It's a patient-reported outcome measure (PROM) recommended for clinical trials.,,AI validation - Sonnet 4.5,0,0,,
7a8ae653-e5f7-45d9-90f4-f5085c37ce2a,Numerical Rating Scale-11,,,,,,,,,,,,PMID:24249806,,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,methods,0.95,"Within the subdomain of pain intensity, the group reviewed the Numerical Rating Scale-11 (NRS-11), the Visual Analogue Scale, and the Faces Pain Scale-Revised using this process.",This is a validated pain assessment scale that was systematically reviewed by the REiNS PRO group. The mining may have missed it due to the hyphenated format (NRS-11) or lack of specific clinical assessment tool patterns.,,AI validation - Sonnet 4.5,0,0,,
51d7596d-4a4a-4ace-90ae-251e921e1ccd,NRS-11,,,,,,,,,,,,PMID:24249806,,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,results,0.95,"However, the NRS-11 was given the highest rating for use in NF clinical trials due to recommendations from pain experts and other consensus groups, its extensive use in research, strong psychometric data including sensitivity to change, and excellent feasibility in ages ≥8 years.",This is the abbreviated form of the Numerical Rating Scale-11. The mining patterns may not have recognized this abbreviated clinical assessment tool name.,,AI validation - Sonnet 4.5,0,0,,
124796ea-eee4-478a-b917-4305eab4765a,Visual Analogue Scale,,,,,,,,,,,,PMID:24249806,,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,methods,0.9,"Within the subdomain of pain intensity, the group reviewed the Numerical Rating Scale-11 (NRS-11), the Visual Analogue Scale, and the Faces Pain Scale-Revised using this process.",This is a widely used pain assessment scale that was systematically reviewed. The mining may have missed it due to lack of specific patterns for this common clinical assessment tool.,,AI validation - Sonnet 4.5,0,0,,
33314510-0dda-4472-a9cd-33998fbfa56a,Faces Pain Scale-Revised,,,,,,,,,,,,PMID:24249806,,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,methods,0.9,"Within the subdomain of pain intensity, the group reviewed the Numerical Rating Scale-11 (NRS-11), the Visual Analogue Scale, and the Faces Pain Scale-Revised using this process.",This is a validated pediatric pain assessment scale that was systematically reviewed. The mining may have missed it due to the compound name format or lack of specific pediatric assessment tool patterns.,,AI validation - Sonnet 4.5,0,0,,
4feaf9f9-a5ed-461c-a650-3cbb7fafed0c,WHO criteria,,,,,,,,,,,,PMID:24500418,,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",results,0.9,...Volumetric tumor measurement detected tumor progression earlier than conventional 2-dimensional (WHO) and 1-dimensional (RECIST) methods...,WHO tumor response criteria are a standardized clinical assessment tool but may have been missed due to abbreviated mention,,AI validation - Sonnet 4.5,0,0,,
4ed62e25-a89e-4e97-9719-a0a46b38053e,RECIST,,,,,,,,,,,,PMID:24500418,,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",results,0.9,...Volumetric tumor measurement detected tumor progression earlier than conventional 2-dimensional (WHO) and 1-dimensional (RECIST) methods...,RECIST (Response Evaluation Criteria in Solid Tumors) is a standardized clinical assessment tool but may have been missed due to abbreviated mention,,AI validation - Sonnet 4.5,0,0,,
afc04c11-f540-4a48-9af6-3ecd0c77fe8b,WISC-III,,,,,,,,,,,,PMID:24559228,,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,methods,0.95,"We administered the Portuguese adapted version of the Wechsler Intelligence Scale for Children (WISC-III), in all participants with NF1",Validated clinical assessment tool (intelligence scale) administered to study participants,,AI validation - Sonnet 4.5,0,0,,
43c7c3ad-cba8-493c-978e-9dde8b16f4b7,NFTI-QOL,,,,,,,,,,,,PMID:24619350,,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,abstract,0.98,The disease-focused NF2 impact on quality of life (NFTI-QOL) patient questionnaire was assessed as an outcome measure for treatment in a multi-centre study.,This is the primary clinical assessment tool being validated and used throughout the study. It's an 8-item questionnaire specifically designed for NF2 patients to measure quality of life impact.,,AI validation - Sonnet 4.5,0,0,,
972c21ea-6d5a-4beb-b9b8-0eb1e581672a,auditory brainstem response,,,,,,,,,,,,PMID:25113746,,A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.,abstract,1.0,"development of cranial nerve VIII tumors correlates with functional impairments in hearing and balance, as measured by auditory brainstem response and vestibular testing",Clinical assessment tools may not be well-covered in bench research mining patterns,,AI validation - Sonnet 4.5,0,0,,
1ecc8de8-1c4e-4c2f-9f88-db1dc493041e,Paper frames method,,,,,,,,,,,,PMID:25475340,,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,methods,0.98,"Paper frames, with a central square measuring 100 cm2, were placed on the back, abdomen and thigh. Images were taken, transferred to a computer and two independent examiners counted the neurofibromas.",This is the main clinical assessment tool developed and validated in this study - a standardized method for quantifying skin neurofibromas using 100cm² paper frames,,AI validation - Sonnet 4.5,0,0,,
5ca2f9b0-6717-4638-ab39-e7ca5fbe808e,Rotarod apparatus,,,,,,,,,,,,PMID:25535838,,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,methods,1.0,Motor function and motor learning were evaluated by rotarod apparatus,Behavioral testing equipment not captured by patterns,,AI validation - Sonnet 4.5,0,0,,
91a8d637-0f1f-4ffa-8963-3f7b7055ed36,National Institutes of Health diagnostic criteria for NF1,,,,,,,,,,,,PMID:25557241,,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,introduction,0.9,"Neurofibromatosis type 1 (NF1, OMIM No. 162200) is a neurocutaneous disorder characterized by café-au-lait macules, freckling, neurofibromas",Standardized diagnostic criteria not captured as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
5622fc02-08bf-4dce-8d91-5b39d049093f,ACMG/AMP classification system,,,,,,,,,,,,PMID:25557241,,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,methods,0.95,Newly described variants (n = 76) were scored using the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) classification system,Variant classification system not recognized as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
e0e33fa3-0a00-442c-8db6-57257af8466c,ESHRE guidelines,,,,,,,,,,,,PMID:25557241,,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,methods,0.85,All PGT assays were designed and validated according to local protocols and ESHRE guidelines,Clinical practice guidelines not captured as assessment tools,,AI validation - Sonnet 4.5,0,0,,
dca38ee5-b02e-4492-a503-db8203cef543,Wechsler Abbreviated Scale of Intelligence (WASI),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,"Full‐Scale IQ of at least 70, as determined by the Wechsler Abbreviated Scale of Intelligence (WASI 15 )",Standard neuropsychological assessment tool with clear usage context and reference number,,AI validation - Sonnet 4.5,0,0,,
8a7a1518-3610-4e41-a17e-ceddcda7c9c2,Brief Visuospatial Memory Test – Revised (BVMT-R),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,"the Brief Visuospatial Memory Test – Revised (BVMT, Immediate and Delayed 19 ; nonverbal declarative memory)",Primary outcome measure - validated neuropsychological test for nonverbal memory assessment,,AI validation - Sonnet 4.5,0,0,,
c25b4d0b-66df-4961-af92-94046daf743b,Letter-Number Sequencing task (LNS),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,the Letter‐Number Sequencing task (LNS 20 ; working memory),Primary outcome measure - standardized working memory assessment tool,,AI validation - Sonnet 4.5,0,0,,
3471553b-f10b-491f-8129-e69a54c43558,Hopkins Verbal Learning Test (HVLT),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,Hopkins Verbal Learning Test (HVLT; verbal declarative memory 22 ),Secondary outcome measure - validated verbal memory assessment tool,,AI validation - Sonnet 4.5,0,0,,
cbc60772-8a74-4d8b-bfce-90044713ed26,Digit Cancellation,,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,Digit Cancellation (attention/inhibitory control) 21,Secondary outcome measure - attention/inhibitory control assessment tool,,AI validation - Sonnet 4.5,0,0,,
cb6283c1-d37c-4640-b926-3461cebdec39,WISC-III Object Assembly,,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,WISC‐III Object Assembly (visuoconstructive ability) 23,Secondary outcome measure - visuoconstructive ability assessment from Wechsler Intelligence Scale,,AI validation - Sonnet 4.5,0,0,,
e91597d5-452e-4957-b4b8-cd6613ca08a1,Achenbach Child Behavior Checklist (CBCL),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,"Achenbach Child Behavior Checklist (CBCL; self‐ and parent‐report) or Young Adult Self Report (YASR) 24 , 25",Secondary outcome measure - validated behavioral assessment questionnaire,,AI validation - Sonnet 4.5,0,0,,
a535b31c-2a69-49f4-8bd5-f880b562e334,Young Adult Self Report (YASR),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,"Achenbach Child Behavior Checklist (CBCL; self‐ and parent‐report) or Young Adult Self Report (YASR) 24 , 25",Secondary outcome measure - validated behavioral assessment questionnaire for adults,,AI validation - Sonnet 4.5,0,0,,
3c868d8e-7aa8-4a2d-a764-ab4fbb2a235e,Neuropsychological Assessment Battery (NAB) Mazes,,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,the Neuropsychological Assessment Battery (NAB) Mazes 26,Tertiary outcome measure - standardized neuropsychological assessment tool,,AI validation - Sonnet 4.5,0,0,,
f26f4501-b8b4-4cc3-a04b-855ba3b6784a,Delis–Kaplan Executive Function Scale (D-KEFS),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,Delis‑Kaplan Executive Function Scale (D‐KEFS) verbal fluency (category and letter fluency) 27,Tertiary outcome measure - executive function assessment battery,,AI validation - Sonnet 4.5,0,0,,
af524a8e-9a67-4204-99f3-9ccd52cf9aa5,Behavior Rating Inventory of Executive Function (BRIEF),,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,1.0,Behavior Rating Inventory of Executive Function (BRIEF; General Executive Composite (GEC) score) 28,Tertiary outcome measure - executive function rating scale,,AI validation - Sonnet 4.5,0,0,,
5c9c30f4-199b-4a0c-a82d-f0042c635730,Spatial Capacity Working Memory (SCAP) task,,,,,,,,,,,,PMID:27081657,,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,methods,0.9,"A spatial working memory functional MRI paradigm, designed to be analogous to the behavioral tasks used in the mouse model",Functional MRI task - specialized working memory assessment tool,,AI validation - Sonnet 4.5,0,0,,
b9fc2929-0468-4154-8655-ce579d2a1c66,Wechsler Adult Intelligence Scale (WAIS-III),,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.95,"General intellectual functioning was assessed by the third version of the Brazilian Wechsler Intelligence Scales (WAIS-III or WISC-III for adults and children, respectively; Wechsler, 2002, 2004).",Standardized clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
ad6c7da6-21cb-44f3-abab-928897bdcf62,Wechsler Intelligence Scale for Children (WISC-III),,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.95,"General intellectual functioning was assessed by the third version of the Brazilian Wechsler Intelligence Scales (WAIS-III or WISC-III for adults and children, respectively; Wechsler, 2002, 2004).",Standardized clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
317678ea-88ef-4c3f-8e06-6c5cc55d4ffb,Digit-span subtest,,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.9,"All participants completed the age-appropriate digit-span subtest of the Wechsler Adult and Children Intelligence Scales (Wechsler, 2002, 2004)",Specific neuropsychological test component not captured,,AI validation - Sonnet 4.5,0,0,,
bb29f436-2c37-45a5-b2d3-19fc22ca0324,Corsi block-tapping task,,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.95,"All participants completed the age-appropriate digit-span subtest of the Wechsler Adult and Children Intelligence Scales (Wechsler, 2002, 2004) and the Corsi block-tapping task (Kessels et al., 2000, 2008).",Visuospatial working memory assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
a7890c9d-cfad-4d59-829c-9d65ddb33fec,School Achievement Test,,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.9,"We adopted the arithmetic subtest from the School Achievement Test (Stein, 1994), as an objective measure of school performance.",Academic assessment tool not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
327db150-a3b5-4920-b475-8648d77c91f7,Brazilian Criterion for Economic Classification (CCEB),,,,,,,,,,,,PMID:27458360,,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,methods,0.85,Socioeconomic status (SES) was assessed using the Brazilian Criterion for Economic Classification (CCEB) according to the criteria established by the Brazilian Research Enterprises Association,Socioeconomic assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
98fa4042-2819-41df-be04-863fd2a8e6af,Digit Span subtest,,,,,,,,,,,,PMID:27527646,,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,abstract,0.9,"The Digit Span subtest from the Wechsler scales was given the highest ratings of the performance measures due to its good psychometrics, feasibility, utility across a wide age range, and extensive use in previous research.","Specific cognitive assessment tool mentioned as highest-rated performance measure, but may have been missed due to subtest naming pattern",,AI validation - Sonnet 4.5,0,0,,
8421f9a5-2b7a-4bcd-b53c-5cc95c2e0b56,Wechsler scales,,,,,,,,,,,,PMID:27527646,,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,abstract,0.95,"The Digit Span subtest from the Wechsler scales was given the highest ratings of the performance measures due to its good psychometrics, feasibility, utility across a wide age range, and extensive use in previous research.","Well-known standardized cognitive assessment battery, but may have been missed due to generic 'scales' terminology",,AI validation - Sonnet 4.5,0,0,,
1e7fb892-ae5e-4184-8f05-4f2071d837d9,Conners scales,,,,,,,,,,,,PMID:27527646,,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,abstract,0.95,The Conners scales achieved the highest ratings of the behavioral questionnaires for similar reasons.,"Standardized behavioral rating questionnaire for ADHD/attention assessment, should have been detected",,AI validation - Sonnet 4.5,0,0,,
a4091ce7-b24a-49be-9a8c-7721841573c1,Numeric Rating Scale-11,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.95,The REiNS PRO group chose the Numeric Rating Scale–11 (≥8 years) to assess pain intensity,Standard clinical assessment tool name not captured by mining patterns - may need pattern for 'Rating Scale' or 'NRS-11',,AI validation - Sonnet 4.5,0,0,,
47623872-a374-4f3d-a063-85fb57ef93a9,NRS-11,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.9,The REiNS PRO group chose the Numeric Rating Scale–11 (≥8 years) to assess pain intensity,Abbreviated form of Numeric Rating Scale-11 - mining may need patterns for common clinical scale abbreviations,,AI validation - Sonnet 4.5,0,0,,
b7606518-5bb6-4509-a29b-f239e8713f7d,Pain Interference Index,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.95,the Pain Interference Index (6–24 years) and the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Scale,Clinical assessment tool name not captured - may need pattern for 'Index' as clinical measure indicator,,AI validation - Sonnet 4.5,0,0,,
ccc56ad4-70bb-48bd-9c0e-a81e05eb925c,PROMIS Pain Interference Scale,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.98,Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Scale (≥18 years) to evaluate pain interference,PROMIS is a well-known clinical assessment system - mining should capture PROMIS scales,,AI validation - Sonnet 4.5,0,0,,
ec9a3520-d5f5-4b86-aca1-c0e4e7126e06,PROMIS Physical Functioning Scale,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.98,the PROMIS Physical Functioning Scale to measure upper extremity function and mobility (≥5 years) for NF clinical trials,Another PROMIS scale that should be captured - indicates need for comprehensive PROMIS pattern matching,,AI validation - Sonnet 4.5,0,0,,
5ef02c4c-1be8-4a48-9ed8-91e3d0fe602d,Patient-Reported Outcome Measurement Information System,,,,,,,,,,,,PMID:27527648,,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,results,0.95,Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Scale (≥18 years),Full name of PROMIS system - mining should capture both abbreviated and full forms,,AI validation - Sonnet 4.5,0,0,,
661aa7dd-28cf-44c8-9a8e-8676d23cba98,"Social Responsiveness Scale, second edition (SRS-2)",,,,,,,,,,,,PMID:27760236,,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,abstract,0.98,"...Distribution of ASD traits (Social Responsiveness Scale, second edition [SRS-2], with T scores of ≥75 associated with a categorical ASD diagnosis)...",Clinical assessment tool not captured by mining patterns focused on lab research tools,,AI validation - Sonnet 4.5,0,0,,
cedc4052-151e-4e2d-86ca-803d397ab652,Conners Rating Scale,,,,,,,,,,,,PMID:27760236,,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,abstract,0.98,"...attention-deficit/hyperactivity disorder (ADHD) traits (4 versions of Conners Rating Scale, with T scores of ≥65 indicating clinically significant ADHD symptoms)...",Clinical assessment tool not captured by mining patterns focused on lab research tools,,AI validation - Sonnet 4.5,0,0,,
219dd8cc-aeee-436c-859b-2cb298eb6f34,optical coherence tomography,,,,,,,,,,,,PMID:27815398,,Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.,abstract,0.9,...who underwent both volumetric MRI analysis and optical coherence tomography (OCT) within 2 weeks of each other were included...OCT measured the average RNFL thickness around the optic nerve...,OCT is a clinical imaging tool used to measure retinal nerve fiber layer thickness - should be captured as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
11c2d9f7-8bfc-4f81-8aee-cfc1623644e8,OCT,,,,,,,,,,,,PMID:27815398,,Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.,methods,0.9,...optical coherence tomography (OCT) within 2 weeks of each other were included. Volumetric measurement...OCT measured the average RNFL thickness around the optic nerve...,OCT abbreviation for optical coherence tomography - clinical imaging tool for retinal assessment,,AI validation - Sonnet 4.5,0,0,,
0604f04c-b8eb-4655-bb38-4a851f0d853b,high-resolution T1-weighted MRI,,,,,,,,,,,,PMID:27815398,,Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.,methods,0.8,"...Volumetric measurement of the entire anterior visual pathway (AVP; optic nerve, chiasm, and tract) was performed using high-resolution T1-weighted MRI...",Specific MRI sequence used for volumetric measurements - clinical imaging tool,,AI validation - Sonnet 4.5,0,0,,
90dd58ea-f3b6-4d13-b51e-13cdf584bc2b,Cambridge Neuropsychological Test Automated Battery Paired Associate Learning task,,,,,,,,,,,,PMID:27956565,,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,methods,0.95,Primary outcomes were total errors on the Cambridge Neuropsychological Test Automated Battery Paired Associate Learning task (visuospatial learning),Specific neuropsychological test name with clear assessment context was not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
860fb25d-13e3-4081-85f2-a8e3338468a2,Test of Everyday Attention for Children,,,,,,,,,,,,PMID:27956565,,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,methods,0.95,and the Score subtest from the Test of Everyday Attention for Children (sustained attention),Validated attention assessment tool with specific subtest mentioned was not captured,,AI validation - Sonnet 4.5,0,0,,
c0cdcca7-335c-493e-8168-656fb514d26f,Cambridge Neuropsychological Test Automated Battery,,,,,,,,,,,,PMID:27956565,,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,methods,0.9,Primary outcomes were total errors on the Cambridge Neuropsychological Test Automated Battery Paired Associate Learning task,Broader test battery name that encompasses multiple cognitive assessments,,AI validation - Sonnet 4.5,0,0,,
fe186866-9a84-40cb-b2a2-1e33f581e9a0,INF1-QOL questionnaire,,,,,,,,,,,,PMID:28193237,,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,methods,0.98,"The Impact of NF1 on Quality of Life (INF1-QOL) questionnaire was developed by a literature search for common terms, focus group (n = 6), semi-structured interviews (n = 21), initial drafts (n =50) and final 14 item questionnaire (n = 50)",Primary tool being developed in this study - should be the main focus of clinical assessment tool mining,,AI validation - Sonnet 4.5,0,0,,
8caae9ee-9ae5-4330-8d18-d2133a3148bf,EuroQol (EQ-5D),,,,,,,,,,,,PMID:28193237,,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,methods,0.95,"The EuroQol questionnaires were completed by the 50 NF1 participants who did the final 14 item INF1-QOL questionnaire. The EuroQol (EQ 5D) contains a global health score and covers Mobility, Self-care, Usual Activities, Pain/Discomfort, Anxiety and Depression",Well-established generic quality of life questionnaire used for validation - standard clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
dc398bfe-7767-433d-8493-ccc9f6a96be9,Riccardi NF severity grade classification,,,,,,,,,,,,PMID:28193237,,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,methods,0.9,"Disease severity was determined using the Riccardi NF severity grade classification 1 to 4. Grades 1 and 2 were amalgamated to ensure adequate numbers in each group. Grades 1 and 2 were deemed mild, grade 3 moderate and grade 4 severe",Clinical severity assessment scale used to grade NF1 disease severity - validated clinical tool,,AI validation - Sonnet 4.5,0,0,,
b90475f8-90c3-4d51-8494-9a6a7e9d8aea,NF Registry questionnaires,,,,,,,,,,,,PMID:28644838,,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",methods,0.9,...The registry questionnaires [ S1 Text ] and consent language [ S2 Text ] were developed in collaboration with two clinicians...Disease-specific questionnaires captured features of current published diagnostic criteria...,Disease-specific questionnaires developed and validated for clinical assessment,,AI validation - Sonnet 4.5,0,0,,
84799780-1537-4212-9d0a-24cb50021e6e,Quality of life questions,,,,,,,,,,,,PMID:28644838,,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",methods,0.85,"...Disease-specific questionnaires captured features of current published diagnostic criteria [ 12 , 13 , 14 ] and a variety of disease manifestations. They also posed quality of life questions...",Quality of life assessment component of the registry questionnaires,,AI validation - Sonnet 4.5,0,0,,
f77842fa-148c-4cd5-86fd-2b42ea1af84c,WASI,,,,,,,,,,,,PMID:28725547,,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,methods,1.0,"IQ data were obtained using either the Matrix Reasoning and Vocabulary subtests from the WASI (Wechsler, 2011) for the NF1 patients",Wechsler Abbreviated Scale of Intelligence is a standardized cognitive assessment tool,,AI validation - Sonnet 4.5,0,0,,
17aaf7bb-ac16-4f42-ab8f-d31ef3d281db,WAIS-IV,,,,,,,,,,,,PMID:28725547,,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,methods,1.0,"the same measures from the Wechsler Adult Intelligence Scale, Version 4 (WAIS-IV; Wechsler, 2014) for the healthy controls",WAIS-IV is a standardized cognitive assessment instrument with version specified,,AI validation - Sonnet 4.5,0,0,,
0ecb3b49-7243-43f7-a209-bc96bbe8d129,Letter-Number Sequencing task,,,,,,,,,,,,PMID:28725547,,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,methods,0.9,"Working memory capacity was measured behaviorally using the University of Maryland Letter–Number Sequencing (LNS) task (Gold et al., 1997)",LNS is a standardized working memory assessment task,,AI validation - Sonnet 4.5,0,0,,
4a54bd13-c072-4759-bde5-25fb2f23cbd3,SCAP task,,,,,,,,,,,,PMID:28725547,,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,methods,0.9,"Spatial capacity working memory (SCAP) task Participants viewed a visual array presenting 1, 3, 5, or 7 circles on the screen",SCAP is a spatial working memory assessment task used in cognitive research,,AI validation - Sonnet 4.5,0,0,,
a1e0e05a-61d1-4868-9751-0bf0d54479c7,Distress Thermometer,,,,,,,,,,,,PMID:28735371,,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,abstract,0.95,"...test the overall usability of the Distress Thermometer (DT) and symptom checklist and concordance of DT ratings between pediatric patients, their caregivers and medical providers...",Clinical assessment tool not captured by current mining patterns. The Distress Thermometer is a validated psychosocial screening instrument widely used in oncology and other medical settings.,,AI validation - Sonnet 4.5,0,0,,
99e6ed5c-15a3-4563-be2d-e74da6874a2a,UK NF2 Genetic Severity Score,,,,,,,,,,,,PMID:28848060,,Genetic Severity Score predicts clinical phenotype in NF2.,methods,1.0,We have assessed NF2 clinical phenotype in 142 patients in relation to the UK NF2 Genetic Severity Score to validate its use as a clinical and research tool.,This is the primary clinical assessment tool being validated in the study but was not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
bffcf627-9695-4a16-88e0-b92c3a4db94b,8-item NF2 disease-specific quality of life score,,,,,,,,,,,,PMID:28848060,,Genetic Severity Score predicts clinical phenotype in NF2.,methods,0.95,"Quality of life was assessed using the 8-item NF2 disease-specific quality of life score (0–24), with good internal reliability (Cronbach's α=0.87).","Specific validated quality of life instrument with scoring range and reliability data, but not caught by mining patterns",,AI validation - Sonnet 4.5,0,0,,
7b6a71fd-5577-4545-96a2-0243843f8ea6,Hearing grade score,,,,,,,,,,,,PMID:28848060,,Genetic Severity Score predicts clinical phenotype in NF2.,methods,0.9,"Hearing grade was assigned based on a score of 1–6, as used within the English NF2 service to indicate suitability for a hearing implant","Standardized 6-point hearing assessment scale used in clinical practice, but not detected",,AI validation - Sonnet 4.5,0,0,,
a3ebaefa-2e2d-476d-8131-f0815388a62b,Speech Discrimination Score,,,,,,,,,,,,PMID:28848060,,Genetic Severity Score predicts clinical phenotype in NF2.,methods,0.85,"grades 1, 2 and 3/4 hearing equating to optimum Speech Discrimination Score (SDS) in the better hearing ear >70%, 50%–70% and below 50%, respectively","Standardized hearing assessment tool (SDS) with specific percentage thresholds, but not caught",,AI validation - Sonnet 4.5,0,0,,
b5330814-b12e-45d3-ab32-7572c122747a,nerve conduction assays,,,,,,,,,,,,PMID:29408605,,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,abstract,0.9,"Recovery of nerve function was assessed by measuring mean contact paw area on a pressure pad 7, 21, 60, and 90 days following nerve injury and by nerve conduction assays at 90 days following injury",Electrophysiological assessment method for measuring nerve function,,AI validation - Sonnet 4.5,0,0,,
38f9f226-b669-43b9-9427-588fd1b9a28b,Wechsler Adult Intelligence Scale-3rd edition (WAIS-III),,,,,,,,,,,,PMID:29566645,,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",methods,1.0,Intellectual function was assessed by using the Portuguese-adapted version of the Wechsler Adult Intelligence Scale-3rd edition (WAIS-III),Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
6558b6e4-69d1-4417-abd4-72244c204417,Stroop Colour and Word Test,,,,,,,,,,,,PMID:29566645,,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",methods,1.0,All the participants performed the standard Stroop Colour and Word Test [ 31 ] composed by two congruent conditions [word (W) and colour (C)] and one incongruent (interference) condition,Validated neuropsychological test not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
5c4d3d6a-70ab-4e08-8841-2b01a71fca0b,Edinburgh Handedness Inventory,,,,,,,,,,,,PMID:29566645,,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",methods,1.0,All the participants but one were right-handed as assessed by the Edinburgh Handedness Inventory [ 29 ],Clinical assessment inventory not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
7c8277ae-7578-464f-82ee-0734f03a79c2,WAIS-III,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.98,General intellectual functioning was assessed by the third version of the Brazilian Wechsler Intelligence Scales (WAIS-III for adults and WISC-III for children),Standardized neuropsychological test not detected,,AI validation - Sonnet 4.5,0,0,,
074e3c10-2e3b-4dad-b35d-17f8337489c9,WISC-III,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.98,General intellectual functioning was assessed by the third version of the Brazilian Wechsler Intelligence Scales (WAIS-III for adults and WISC-III for children),Standardized neuropsychological test not detected,,AI validation - Sonnet 4.5,0,0,,
3c82d0eb-4e5c-40e0-b4d0-ada78ffae22e,Nine-Hole Peg Test,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,The Nine-Hole Peg Test was performed as a measure of finger dexterity. It measures the time (in seconds) needed to complete the test,Motor assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
3423b42c-636d-404d-8a3c-92bc15d548a1,Rey-Osterrieth Complex Figure Test,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,The Rey-Osterrieth Complex Figure Test was implemented as a measure of the visuospatial cognitive domain,Neuropsychological assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
343d97a3-be49-4132-9efd-41d92bbf56af,Rey Auditory-Verbal Learning Test,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,Immediate (A6) and delayed recalls (A7) of the Brazilian-Portuguese version of the Rey Auditory-Verbal Learning Test (RAVLT),Memory assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
7d32897b-6c88-4e56-90a2-ee0dea38845e,Five Digits Test,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,The Five Digits Test (FDT) is a numeric-Stroop paradigm designed to assess attentional processes,Attention assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
58a5a0cd-eaec-4b51-853d-c2f51939d673,Corsi block-tapping task,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,"For working memory evaluation, we used the Digit Span according to the WAIS-III or WISC-III, and the Corsi block-tapping task",Working memory assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
98914780-0bf5-494f-bebb-6136c88300f4,Tower of London Test,,,,,,,,,,,,PMID:30192842,,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,methods,0.95,The Tower of London Test was used as a measure of Planning Skills,Executive function assessment tool not detected,,AI validation - Sonnet 4.5,0,0,,
74afe9c8-4372-45e6-9a2c-7eda4ba96a62,hearing assessment techniques,,,,,,,,,,,,PMID:30617350,,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",abstract,0.8,...apply state-of-the-art intravital imaging and hearing assessment techniques to study tumor growth and hearing loss...,Assessment methodology mentioned but not captured by clinical tool patterns,,AI validation - Sonnet 4.5,0,0,,
40180160-b86a-44f3-a771-5541f4629361,Burden of Neurofibromatosis (BoN) questionnaire,,,,,,,,,,,,PMID:31053133,,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,methods,1.0,"This study sought to develop a self-administered questionnaire in French to assess the burden of NF1 (BoN), then translate and linguistically and cross-culturally validate it into American English",This is the primary tool being developed in this study - a 15-item questionnaire with 4 domains measuring NF1 burden. Should have been captured as a newly developed clinical assessment tool.,,AI validation - Sonnet 4.5,0,0,,
2b60768b-1169-40d6-a96b-ffa0872da2e1,Dermatology Life Quality Index (DLQI),,,,,,,,,,,,PMID:31053133,,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,methods,1.0,all participants were asked to complete three previously validated self-administered questionnaires: the Dermatology Life Quality Index [DLQI] questionnaire,Established dermatology-specific quality of life questionnaire used for external validation. Clear clinical assessment tool with specific scoring (0-30 scale).,,AI validation - Sonnet 4.5,0,0,,
97356056-88b1-42f9-a8cb-81d17c1a81a5,Perceived Stress Scale (PSS),,,,,,,,,,,,PMID:31053133,,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,methods,1.0,"The PSS is the most widely used psychological instrument for measuring the perception of stress. Composed of 10 items rated from 'never' to 'often', PSS measures the degree to which situations in one's life are perceived as stressful",Validated 10-item psychological stress assessment scale with specific scoring (10-50 range). Standard clinical assessment tool.,,AI validation - Sonnet 4.5,0,0,,
0a2d21cf-fd5b-440e-9f9c-10d4df66f841,SF12,,,,,,,,,,,,PMID:31053133,,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,methods,1.0,"The SF12 is a short version of the SF-36, namely a generic instrument to measure population health, with a physical composite score and mental composite score calculated based on 12 questions",Well-established 12-item health survey instrument with physical and mental composite scores. Standard clinical assessment tool for health-related quality of life.,,AI validation - Sonnet 4.5,0,0,,
df738940-a4ea-4c6c-b7c3-c18c8defa3d6,Social Responsiveness Scale 2nd Edition,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete...,Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
9adcab0a-eda7-49bf-b389-5956eb54659f,SRS-2,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...NF1 participants that screen at risk for ASD on the basis of their SRS-2 results (total symptom T-score≥60)...,Abbreviated form of clinical assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
0a51448a-b764-438d-839e-a3a6a9de862e,Autism Diagnostic Observation Scale 2nd Edition,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria...,Standard diagnostic instrument name not captured,,AI validation - Sonnet 4.5,0,0,,
fbe943ab-c42f-4cc9-aa8a-a88fe0eee304,ADOS-2,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...The ADOS-2 is a semi-structured, standardised child-direct observational assessment designed to assess reciprocal social interaction...",Abbreviated diagnostic instrument name not captured,,AI validation - Sonnet 4.5,0,0,,
494ad412-fe3f-408d-b307-c16a607964e4,Autism Diagnostic Interview-Revised,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...The ADI-R is a semistructured, standardised diagnostic interview designed to assess core aspects of ASD...",Standard diagnostic instrument name not captured,,AI validation - Sonnet 4.5,0,0,,
e08b294c-045d-4b03-ab01-404513c66856,ADI-R,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...The ADI-R is administered to a parent/caregiver by a trained clinician and consists of 95 items...,Abbreviated diagnostic instrument name not captured,,AI validation - Sonnet 4.5,0,0,,
e492746f-e336-47d3-a869-d9274af6500d,WISC-V,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...WISC-V 10 subtests providing 5 indices and full scale IQ S...,Cognitive assessment tool abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
f19c4d27-d52a-4653-85dd-12cd2c9a2518,"Wechsler Intelligence Scale for Children, 5th edition",,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...WISC-V, Wechsler intelligence scale for children, 5th edition...",Full cognitive assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
86567c6c-8c36-4528-86bc-102ab2fbd3ac,WPPSI-IV,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...WPPSI-IV 10 subtests providing 5 indices and full scale IQ Y...,Cognitive assessment tool abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
2834624d-3d3c-4226-8d88-977709c7b5d6,"Wechsler Preschool and Primary Scale of Intelligence, 4th edition",,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...WPPSI IV, Wechsler preschool and primary scale of intelligence, 4th edition...",Full cognitive assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
7283b215-d6b8-4996-bc91-63356323b6cc,NEPSY-II,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...NESPY-II Inhibition 6 items assessing the ability to inhibit automatic responses...,Neuropsychological assessment battery abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
7e512563-c544-4829-8493-2d7481fe40b2,BRIEF,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...BRIEF 86 items assessing executive functions in the home environment...,Executive function rating scale abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
2246b692-783a-4233-a1c5-77bc5b98b180,Behavior Rating Inventory of Executive Functions,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...BRIEF, behavior rating inventory of executive functions...",Full executive function assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
dedcc74c-c0c6-4954-8282-4d6e7b5858af,CBCL,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...CBCL: 6–18 years 113 items assessing internalising and externalising problems...,Behavioral checklist abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
8860655f-6a5e-4ac1-8159-1d1a5305b24c,Child Behavior Checklist,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...CBCL, child behavior checklist...",Full behavioral assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
36e59190-82ca-45f3-bc27-ebb2580db0f9,ABAS-3,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...ABAS-3: 0–5 years 241 items assessing adaptive functioning skills...,Adaptive behavior assessment abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
58683aa8-211f-40df-886a-5e0e1c434f7c,"Adaptive Behavior Assessment System, 3rd edition",,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...ABAS-3, adaptive behaviour assessment system, 3rd edition...",Full adaptive behavior assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
c596fecf-e8cb-4442-9eed-fddbb495c92c,Conners 3,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,...Conners 3 110 items assessing ADHD symptom and comorbid disorders...,ADHD rating scale name not captured,,AI validation - Sonnet 4.5,0,0,,
3d4639f4-b297-42f3-9dac-2f45cd12411e,SSIS Rating Scale,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...SSIS Rating Scale 79 items assessing social skills, problem behaviours and academic competence...",Social skills rating scale name not captured,,AI validation - Sonnet 4.5,0,0,,
44e066f2-08f0-4bd9-9be1-c0aec9b26b48,Social Skills Improvement System,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...SSIS, social skills improvement system...",Full social skills assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
8fa3f2fc-740e-4003-af0d-1798dd4d0ed8,Sensory Profile 2,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...Sensory Profile 2 86 items assessing sensory processing, including auditory, visual, taste/smell...",Sensory processing assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
6fad5a09-59ca-42dd-aa90-8732e2430377,CCC-2,,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...CCC-2 70 items assessing speech, syntax, semantics, coherence...",Communication checklist abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
74bb9e56-5637-4be8-ac5f-ece4e23792d8,"Children's Communication Checklist, 2nd edition",,,,,,,,,,,,PMID:31558455,,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,methods,1.0,"...CCC-2, children's communication checklist, 2nd edition...",Full communication assessment tool name not captured,,AI validation - Sonnet 4.5,0,0,,
7f9ab4c8-82de-4149-93a7-fa636ec922dc,World Health Organization (WHO) criteria,,,,,,,,,,,,PMID:32193437,,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,methods,0.9,...Measurements of the neurofibroma regions were made using the World Health Organization (WHO) criteria on the LAVA post contrast MR scans...,Standardized clinical measurement criteria for tumor assessment,,AI validation - Sonnet 4.5,0,0,,
c0849087-c57e-45da-8a0b-e80f55ef0bcf,"International Classification of Diseases, 10th Revision",,,,,,,,,,,,PMID:32406525,,Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.,abstract,0.8,"...We searched hospital electronic medical records (EMR) for International Classification of Diseases, 10th Revision NF1 and co-occurring diagnoses codes...","ICD-10 is a standardized diagnostic classification system used for clinical assessment, but may not be recognized as a clinical tool",,AI validation - Sonnet 4.5,0,0,,
9a1b8418-3261-4838-922c-ea5b04d172fa,SF-36,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,"Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain interference)",Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
0571b96e-9c46-4b38-b959-c6503ceeb283,EQ-5D-5L,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,"Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain interference)",Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
c1c90b88-6428-40c6-bc0d-3a9207698b25,PROMIS pain interference,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,"Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain interference)",PROMIS tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
aefa6196-f83c-4c46-a715-e12c6ccdc58c,PedsQL NF1 module,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,disease-specific questionnaires (PedsQL NF1 module and the NFTI-QOL for NF2),Disease-specific questionnaire name not captured,,AI validation - Sonnet 4.5,0,0,,
44c7d72e-84f3-4cc7-b99e-6b6f54ffa011,NFTI-QOL,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,disease-specific questionnaires (PedsQL NF1 module and the NFTI-QOL for NF2),NF2-specific quality of life tool not captured,,AI validation - Sonnet 4.5,0,0,,
24459b4c-f846-460d-b8af-accf3878eb69,Ablon visibility index,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.9,the clinicians also rated the disease visibility using the Ablon visibility index,Clinical rating scale not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
051b935b-7cfe-4044-87f9-b072c36838c7,House and Brackmann facial nerve scale,,,,,,,,,,,,PMID:32642740,,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,methods,0.95,physicians also completed the House and Brackmann facial nerve scale that rates facial nerve impairments from 1—normal symmetric function to 6—indicating complete paralysis,Clinical rating scale with specific name not captured,,AI validation - Sonnet 4.5,0,0,,
aa1c9896-e4ef-41e0-b646-8ce3dbf26e71,PlexiQoL,,,,,,,,,,,,PMID:33085177,,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,methods,1.0,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas...The PlexiQoL is the first disease-specific PRO assessing the ability of adults with NF-1 associated pNFs to meet their basic human needs.,This is the primary clinical assessment tool being developed in this study - a patient-reported outcome measure specifically for NF1 patients with plexiform neurofibromas,,AI validation - Sonnet 4.5,0,0,,
7d1790a2-f92d-4480-9745-09f2642a436d,Nottingham Health Profile,,,,,,,,,,,,PMID:33085177,,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,methods,1.0,"The comparator measure used in the UK was the Nottingham Health Profile (NHP; Hunt et al., 1981)...The NHP comprises six sections; energy level, pain, physical mobility, sleep, social isolation, and emotional reactions.",This is an established clinical assessment tool used as a comparator measure in the validation study,,AI validation - Sonnet 4.5,0,0,,
701a0dea-5d4c-4fc3-bff2-ef5e134a0226,Short Form-36,,,,,,,,,,,,PMID:33085177,,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,methods,1.0,"the Short Form‐36 (SF‐36; Ware & Sherbourne, 1992) was used in the US. These are generic measures of subjective health status (HRQL). The SF‐36 consists of 36 items, covering eight sections.",This is an established clinical assessment tool (SF-36) used as a comparator measure in the US portion of the validation study,,AI validation - Sonnet 4.5,0,0,,
23a6e189-06b7-4fb6-985f-69485f708e83,PHQ-9,,,,,,,,,,,,PMID:33197677,,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,abstract,0.95,"...completed measures of depression (PHQ-9) and perceived stress (PSS-10) at baseline, post-intervention, and six-month follow-up.",This is a validated depression assessment scale that should have been detected as a clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
401586eb-4f2d-4a08-977f-6e95af17d0d3,PSS-10,,,,,,,,,,,,PMID:33197677,,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,abstract,0.95,"...completed measures of depression (PHQ-9) and perceived stress (PSS-10) at baseline, post-intervention, and six-month follow-up.",This is a validated perceived stress scale that should have been detected as a clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
c323f250-4fc2-46b6-bb96-89ee338a3f6f,Numerical Rating Scale-11,,,,,,,,,,,,PMID:33507822,,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,methods,0.95,The Numerical Rating Scale-11 is a self-report measure of pain intensity that was adapted to assess PN-related pain for NF1 clinical trials. Patients were asked to choose their most important tumor pain and rate it from 0 (no pain) to 10 (worst pain) in the past week.,Clinical assessment tool with specific name and validation context not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
1ae9f7fc-fd23-422b-97a6-054a60033dd3,Brief Pain Inventory Pain Interference subscale,,,,,,,,,,,,PMID:33507822,,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,methods,0.95,The Brief Pain Inventory Pain Interference subscale assesses the impact of pain on daily functioning in seven areas from 0 (does not interfere) to 10 (completely interfered) in the past week; it yields a mean total score.,Validated clinical assessment instrument with specific subscale name not captured,,AI validation - Sonnet 4.5,0,0,,
637f18ee-189b-492d-9331-44431ab8cae0,Pediatric Quality of Life Inventory NF1 module,,,,,,,,,,,,PMID:33507822,,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,methods,0.95,The Pediatric Quality of Life Inventory NF1 module is a disease-specific health-related quality-of-life (QOL) measure assessing 16 domains. Responses on a five-point Likert scale are transformed to a scale of 0-100 (higher scores = better QOL),Disease-specific quality of life instrument with detailed scoring description not captured,,AI validation - Sonnet 4.5,0,0,,
7f490f75-6374-4eda-99aa-5855478ad421,P.L.E.A.S.E.® device,,,,,,,,,,,,PMID:33817379,,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,methods,0.95,"cNFs were laser-porated using the P.L.E.A.S.E.® device with the following user-defined settings: density of 10%, 5 pulses per pore, repetition rate of 300 Hz, pulse duration of 125 μs, pore array size of 10mm and fluence of 36.2 J/cm2",Medical device with specific technical parameters not captured by current mining patterns,,AI validation - Sonnet 4.5,0,0,,
f3665628-d6d5-4c9b-a0ba-a29437604b55,Dermlite DL3,,,,,,,,,,,,PMID:33817379,,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,methods,0.9,"visual and dermatoscopy observations (using the Dermlite DL3 [3Gen, San Jan Capistrano, CA, USA]) noting color and presence of necrosis, presence of flaccidity, and size",Clinical assessment device with manufacturer information not detected,,AI validation - Sonnet 4.5,0,0,,
3600d273-3445-4a2a-9fd2-a2950a2f4466,NIH Consensus Development Conference NF1 diagnostic criteria,,,,,,,,,,,,PMID:33817379,,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,methods,0.85,"patients with a clinical diagnosis of NF1 according to the NIH Consensus Development Conference NF1 diagnostic criteria (NIH, 1998)",Standardized diagnostic criteria used for patient selection - represents a clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
bc2c1bd5-802e-4103-95b9-01baefb70e70,n-back task,,,,,,,,,,,,PMID:33963966,,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,abstract,0.8,EEG was recorded during a WM nback task. The NF1 group showed poorer performance on measures of WM,"The n-back task is a standardized cognitive assessment tool for working memory, but may not have been recognized by mining patterns focused on questionnaire names",,AI validation - Sonnet 4.5,0,0,,
6097c20b-f9a9-4c4e-8a35-4a874d4b3590,Mullen Scales of Early Learning (MSEL),,,,,,,,,,,,PMID:34049498,,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,methods,0.95,"The Mullen Scales of Early Learning (MSEL) is a standardised measure that assesses developmental ability across five domains: Gross Motor, Visual Reception, Fine Motor, Receptive Language and Expressive Language.",Standardized developmental assessment tool not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
8d9f081b-eeb0-4d54-a917-4aa6ff2b6347,Autism Observation Score for Infants (AOSI),,,,,,,,,,,,PMID:34049498,,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,methods,0.95,The Autism Observation Score for Infants (AOSI) is a standardised research assessment that examines ASD traits in infants in the first two years of life.,Standardized autism assessment tool not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
d59bf5f7-cc6e-46ce-a0dd-ce70633a3aa2,Infant Behaviour Questionnaire-Revised (IBQ-R),,,,,,,,,,,,PMID:34049498,,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,methods,0.95,"To measure ADHD-related early behaviours, we used the Activity Level subscale of the Infant Behaviour Questionnaire-Revised. The IBQ-R is a parent-report questionnaire consisting of 191 items and 14 scales that relate to different aspects of infant temperament.",Standardized temperament questionnaire not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
bef80b95-5af3-4be1-a313-799ba46734c3,MacArthur Bates Communicative Development Inventory (CDI),,,,,,,,,,,,PMID:34049498,,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,methods,0.95,"Parents completed the MacArthur Bates Communicative Development Inventory (CDI) long form. The CDI measures early language abilities by assessing vocabulary comprehension and expression, use of gestures and grammar.",Standardized language development assessment not detected by mining patterns,,AI validation - Sonnet 4.5,0,0,,
89c46e40-c844-40be-a3b5-57c9f4f2c18a,PedsQL,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,abstract,1.0,"...parent-reported questionnaires (PedsQL™, CBCL/6-18). Six children completed...",Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
d2a1b206-35a4-4be3-b41a-9bbaed072591,PedsQL Generic 4.0,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,methods,1.0,"...Quality of life was assessed by parent reported questionnaires, including the Pediatric Quality of Life (PedsQL™) Generic 4.0 and Neuromuscular (3.0) modules...",Specific version of PedsQL not captured,,AI validation - Sonnet 4.5,0,0,,
da4d80b5-9d4a-47d7-b432-d72883e40e39,PedsQL Neuromuscular 3.0,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,methods,1.0,...the Pediatric Quality of Life (PedsQL™) Generic 4.0 and Neuromuscular (3.0) modules...,Specific neuromuscular module not captured,,AI validation - Sonnet 4.5,0,0,,
69d6afa2-e02d-4bcd-8086-7f2a8ea5d4ad,CBCL/6-18,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,abstract,1.0,"...parent-reported questionnaires (PedsQL™, CBCL/6-18). Six children completed...",Standard behavioral assessment tool abbreviation not captured,,AI validation - Sonnet 4.5,0,0,,
d5f71ec3-9755-424d-95b1-dd7e7058cf36,Child Behavior Checklist for ages 6-18,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,methods,1.0,"...Quality of life was assessed by parent reported questionnaires, including the Pediatric Quality of Life (PedsQL™) Generic 4.0 and Neuromuscular (3.0) modules, and The Child Behavior Checklist for ages 6–18 or CBCL/6–18...",Full name of behavioral assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
6a1145e9-8713-4c59-b6b7-6b825e67a557,6-minute-walk test,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,abstract,0.9,"...functional measures (muscle strength, long jump, handwriting speed, 6-minute-walk test [6MWT])...",Standardized functional assessment test not captured,,AI validation - Sonnet 4.5,0,0,,
73e7c28c-f480-4c40-bcc3-41c41fce6720,6MWT,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,abstract,0.9,"...handwriting speed, 6-minute-walk test [6MWT]), and parent-reported...",Abbreviation for 6-minute walk test not captured,,AI validation - Sonnet 4.5,0,0,,
fe0f6483-0d33-4e5a-968e-fa7cd6a8ea4f,Handwriting Speed Test,,,,,,,,,,,,PMID:34155781,,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,methods,0.9,"...Fine motor endurance was evaluated by the Handwriting Speed Test (Wallen et al., 1996) that gives a raw score in letters per minute...",Standardized motor assessment test not captured,,AI validation - Sonnet 4.5,0,0,,
e9c07396-f38e-4640-8589-8a6463935ec3,Handheld Dynamometry,,,,,,,,,,,,PMID:34230196,,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,abstract,0.95,we evaluated the intraobserver reliability of handheld dynamometry (HHD) and developed consensus recommendations for its use in NF clinical trials,"This is the primary clinical assessment tool being validated in the study. HHD is a standardized measurement technique for assessing muscle strength, which is a legitimate clinical assessment tool that should be captured.",,AI validation - Sonnet 4.5,0,0,,
b31d7a29-862c-4d60-a877-af6e74f78949,Manual Muscle Testing,,,,,,,,,,,,PMID:34230196,,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,abstract,0.9,Patients ≥5 years of age with weakness in at least 1 muscle group by manual muscle testing (MMT) were eligible,MMT is a standardized clinical assessment protocol for evaluating muscle strength. It's a well-established clinical assessment tool used for patient screening and outcome measurement.,,AI validation - Sonnet 4.5,0,0,,
2a87d1cd-4010-4e78-8102-04a7d80a506f,Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,The highest-rated generic measures were (1) the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales for NF clinical trials for children or for children through adults,Clinical assessment tool pattern likely doesn't capture full instrument names with parenthetical abbreviations,,AI validation - Sonnet 4.5,0,0,,
5444a551-01ca-4004-b581-d619baf3f103,PedsQL,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales for NF clinical trials,Abbreviated form of clinical assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
c2125901-c69e-41c7-b418-51c47cd1c40d,Functional Assessment of Cancer Therapy-General,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,(2) the Functional Assessment of Cancer Therapy-General for adult medical trials,Clinical assessment tool pattern doesn't capture hyphenated instrument names,,AI validation - Sonnet 4.5,0,0,,
359be98f-f6c4-452a-a59b-f739655f34ca,World Health Organization Quality of Life-BREF,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,(3) the World Health Organization Quality of Life-BREF for adult psychosocial trials,WHO instrument name with abbreviation not captured by patterns,,AI validation - Sonnet 4.5,0,0,,
3b691bdf-cead-492d-af5f-8d55e7cd4915,PedsQL NF1 Module,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,The highest-rated disease-specific measures were (1) the PedsQL NF1 Module for NF1 trials,Disease-specific module of clinical assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
65e11557-8f78-4618-8bf9-4adff1c3bb71,NF2 Impact on Quality of Life Scale,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,(2) the NF2 Impact on Quality of Life Scale for NF2 trials,Disease-specific quality of life scale not captured,,AI validation - Sonnet 4.5,0,0,,
56d62869-2311-4de3-b6bc-3934a54034a4,Penn Acoustic Neuroma Quality of Life Scale,,,,,,,,,,,,PMID:34230198,,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,abstract,1.0,(3) the Penn Acoustic Neuroma Quality of Life Scale for NF2 trials targeting vestibular schwannomas,Institution-specific clinical assessment scale not captured,,AI validation - Sonnet 4.5,0,0,,
71b43df0-d131-455a-8642-f03958104538,Self-Assessment of Communication,,,,,,,,,,,,PMID:34230203,,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,abstract,0.95,"The Self-Assessment of Communication and the Self-Assessment of Communication-Adolescent were identified as most useful for adult and pediatric populations with NF2, respectively, for the measurement of both hearing function and hearing-related QoL.",This is the primary recommended clinical assessment tool but was not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
ba11e9f9-65a6-415b-a228-c9fe9dfcdf2d,Self-Assessment of Communication-Adolescent,,,,,,,,,,,,PMID:34230203,,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,abstract,0.95,"The Self-Assessment of Communication and the Self-Assessment of Communication-Adolescent were identified as most useful for adult and pediatric populations with NF2, respectively, for the measurement of both hearing function and hearing-related QoL.",This is the primary recommended pediatric clinical assessment tool but was not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
afcd1040-2de3-4848-82e9-217c66b36015,REiNS rating procedures,,,,,,,,,,,,PMID:34230203,,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,methods,0.8,The REiNS Patient-Reported Outcomes Working Group systematically evaluated published patient-reported outcome measures of (1) hearing function and (2) hearing-related QoL for individuals with hearing loss of various etiologies using previously published REiNS rating procedures.,This is a systematic evaluation methodology/tool used for assessment but was not captured,,AI validation - Sonnet 4.5,0,0,,
f7d3e6ec-f2fd-4150-a1cd-782d939e8eb7,Skindex,,,,,,,,,,,,PMID:34230204,,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,abstract,0.95,"...explore the use of Skindex scoring in patients with neurofibromatosis type 1 (NF1) across multiple clinical sites...analyzed correlations between Skindex, site, and clinical measures...Female sex, total number of cutaneous neurofibroma (cNF), and whether cNF were present on the face correlated highly with Skindex...",Clinical assessment tool name 'Skindex' not recognized by mining patterns. This is a validated dermatology-specific quality of life questionnaire.,,AI validation - Sonnet 4.5,0,0,,
5658a955-0ffa-4921-9d59-a9d0be3481d0,Riccardi scores,,,,,,,,,,,,PMID:34230204,,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,abstract,0.85,"...Female sex, total number of cutaneous neurofibroma (cNF), and whether cNF were present on the face correlated highly with Skindex and not Riccardi scores...",Clinical assessment tool 'Riccardi scores' not recognized. This appears to be a clinical scoring system for NF1 assessment.,,AI validation - Sonnet 4.5,0,0,,
e07c2ce8-1865-4d0b-8769-5f6d22854931,Social Responsiveness Scale-2 (SRS-2),,,,,,,,,,,,PMID:34230205,,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,abstract,0.98,Two measures were ultimately recommended by the committee: the Social Responsiveness Scale-2 (SRS-2) and the Social Skills Improvement System-Rating Scale (SSIS-RS).,This is a validated clinical assessment tool specifically recommended for NF1 clinical trials. Should have been captured as it's a primary outcome of the study.,,AI validation - Sonnet 4.5,0,0,,
5126a2dc-1ab8-4d86-bac5-aee21670969c,Social Skills Improvement System-Rating Scale (SSIS-RS),,,,,,,,,,,,PMID:34230205,,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,abstract,0.98,Two measures were ultimately recommended by the committee: the Social Responsiveness Scale-2 (SRS-2) and the Social Skills Improvement System-Rating Scale (SSIS-RS).,This is a validated clinical assessment tool specifically recommended for NF1 clinical trials. Should have been captured as it's a primary outcome of the study.,,AI validation - Sonnet 4.5,0,0,,
c01c9318-a1c6-4033-b547-5c8e81e8766a,modified free listing technique,,,,,,,,,,,,PMID:34230208,,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,methods,0.8,...Facilitators and barriers to patient representative involvement were solicited using a modified free listing technique; responses were inductively grouped...,Specific qualitative research methodology not in standard clinical assessment patterns,,AI validation - Sonnet 4.5,0,0,,
9b060918-3b3e-4aa4-a718-0bdf839e4a28,saliency score,,,,,,,,,,,,PMID:34230208,,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,methods,0.75,...responses were inductively grouped into higher-order categories and ranked based on saliency score (Smith...,Specific scoring methodology with citation - may not be in assessment tool patterns,,AI validation - Sonnet 4.5,0,0,,
adbabc72-0498-4765-a1f8-62e156a0c293,Cogstate,,,,,,,,,,,,PMID:34377779,,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,methods,0.95,Performance tasks (Cogstate) and observer-reported functioning (BRIEF) were the primary outcomes...computerized assessment battery (Cogstate) targeting neurocognitive processes,Clinical assessment tool name not recognized by mining patterns - needs specific pattern for computerized cognitive assessment batteries,,AI validation - Sonnet 4.5,0,0,,
316b59ab-b895-48bd-88aa-cc4ea5c33494,BRIEF,,,,,,,,,,,,PMID:34377779,,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,methods,0.98,observer-reported functioning (BRIEF) were the primary outcomes...a consistent parent completed a questionnaire of executive functioning (Behavior Rating Inventory of Executive Function; BRIEF),Acronym for clinical assessment tool not captured - needs pattern for BRIEF and its full name 'Behavior Rating Inventory of Executive Function',,AI validation - Sonnet 4.5,0,0,,
d4d9d44e-5178-4b68-8595-c6b603031e2b,Scales of Independent Behavior-Revised Motor Scale,,,,,,,,,,,,PMID:34664663,,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,methods,0.95,Motor functioning was assessed longitudinally using the Scales of Independent Behavior-Revised Motor Scale and the Differential Ability Scales-II Copying subtest.,"This is a validated clinical assessment tool for measuring motor functioning, but may not have been recognized by mining patterns focused on laboratory tools",,AI validation - Sonnet 4.5,0,0,,
5b2bbeac-4ef4-43b6-a7b4-3bb0377a0cce,Differential Ability Scales-II Copying subtest,,,,,,,,,,,,PMID:34664663,,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,methods,0.9,Motor functioning was assessed longitudinally using the Scales of Independent Behavior-Revised Motor Scale and the Differential Ability Scales-II Copying subtest.,"This is a standardized developmental assessment tool, specifically the copying subtest which measures fine motor skills and visual-motor integration",,AI validation - Sonnet 4.5,0,0,,
5ed349ac-732d-45d7-9dff-7e48849b06db,Manchester Criteria,,,,,,,,,,,,PMID:35332608,,Re-evaluation of missense variant classifications in NF2.,methods,0.85,"patients who fitted Manchester Criteria for NF2 disease (Table S1) (Evans et al., 1992; Smith et al., 2017) were considered to have phenotypic specificity",Clinical diagnostic criteria used for patient phenotype classification,,AI validation - Sonnet 4.5,0,0,,
568b9fd5-41d3-41df-b675-45ca47a389bf,CNC-word test,,,,,,,,,,,,PMID:35723774,,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,abstract,0.9,Speech perception ability in background noise was evaluated in device-active and inactive conditions using the CNC-word test.,Clinical assessment tool not captured - may need patterns for speech/hearing assessment tools,,AI validation - Sonnet 4.5,0,0,,
99240e25-a548-409c-b7a3-244d446eec83,LIFE-R Questionnaire,,,,,,,,,,,,PMID:35723774,,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,abstract,0.95,Listening and communication ratings (LIFE-R Questionnaire) were obtained at baseline and at the end of each treatment phase.,Clinical questionnaire not captured - may need patterns for questionnaire/rating scale detection,,AI validation - Sonnet 4.5,0,0,,
0369d238-4a09-40cc-a5b1-0e567ffd6d87,NFTI-QOL-D,,,,,,,,,,,,PMID:36604703,,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,abstract,0.98,The aim of this study was to produce and validate a German version of the NFTI-QOL (NFTI-QOL-D) and to correlate QOL scores with a depression score,This is the primary clinical assessment tool being developed and validated in this study. Should have been detected as it's explicitly named and described as a questionnaire.,,AI validation - Sonnet 4.5,0,0,,
ae81e44a-22a1-4264-b039-2c9353fe56db,NFTI-QOL,,,,,,,,,,,,PMID:36604703,,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,abstract,0.95,The NFTI-QOL questionnaire has produced useful results in English-speaking cohorts. The aim of this study was to produce and validate a German version of the NFTI-QOL,This is the original English version of the quality of life questionnaire that serves as the basis for the German translation. Clear questionnaire context.,,AI validation - Sonnet 4.5,0,0,,
23f9a1b5-ae68-4aa1-a7c7-a3a52da2f55c,PHQ-9,,,,,,,,,,,,PMID:36604703,,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,abstract,0.98,correlate QOL scores with a depression score (PHQ-9) and clinical disease severity,PHQ-9 is a well-established depression assessment questionnaire used as a validation comparator. Should be detected as clinical assessment tool.,,AI validation - Sonnet 4.5,0,0,,
23496020-9c01-4460-b152-f7610592a4d0,Disease severity score,,,,,,,,,,,,PMID:36604703,,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,methods,0.85,The utilised clinician-reported disease severity score is based on the presence or absence of 7 symptoms with major impact on the patient's life,This is a validated clinical assessment tool used to measure disease severity. Described as having been validated for internal consistency and correlation with clinical parameters.,,AI validation - Sonnet 4.5,0,0,,
e8895b83-4022-48c5-b949-74067603f634,PedsQL,,,,,,,,,,,,PMID:37276689,,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,abstract,0.98,...investigate health-related quality of life (HRQoL) in children with Neurofibromatosis Type 1 (NF1) using the Pediatric Quality of Life inventory (PedsQL) and the Child Health Questionnaire (CHQ)...,Clinical assessment tool not detected - PedsQL is a well-established validated questionnaire for measuring pediatric quality of life,,AI validation - Sonnet 4.5,0,0,,
87723029-2129-43bf-88f2-2487935a1078,Pediatric Quality of Life inventory,,,,,,,,,,,,PMID:37276689,,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,abstract,0.98,...investigate health-related quality of life (HRQoL) in children with Neurofibromatosis Type 1 (NF1) using the Pediatric Quality of Life inventory (PedsQL) and the Child Health Questionnaire (CHQ)...,Full name of PedsQL questionnaire not detected - this is the formal name of the validated assessment tool,,AI validation - Sonnet 4.5,0,0,,
96cf8fbb-7c2a-4da6-9df5-665f3614b4c2,CHQ,,,,,,,,,,,,PMID:37276689,,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,abstract,0.98,...using the Pediatric Quality of Life inventory (PedsQL) and the Child Health Questionnaire (CHQ); and (2) compare the psychometric properties...,Clinical assessment tool abbreviation not detected - CHQ is a validated questionnaire for child health assessment,,AI validation - Sonnet 4.5,0,0,,
075b21fe-f632-4b49-8934-9d820467a8a7,Child Health Questionnaire,,,,,,,,,,,,PMID:37276689,,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,abstract,0.98,...using the Pediatric Quality of Life inventory (PedsQL) and the Child Health Questionnaire (CHQ); and (2) compare the psychometric properties...,Full name of CHQ questionnaire not detected - this is the formal name of the validated assessment tool,,AI validation - Sonnet 4.5,0,0,,
d54dce9d-fcd2-4288-954f-cc99fa2cefa5,Burden of Neurofibromatosis 1 questionnaire (BoN),,,,,,,,,,,,PMID:37353850,,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,abstract,0.95,The aim of this study was to evaluate the psychometric properties of the burden of neurofibromatosis 1 questionnaire (BoN) and to determine the perceived disease burden. RESULTS: The 15-item BoN was translated into Persian,The mining patterns likely didn't capture the full questionnaire name or the abbreviation 'BoN'. The tool is clearly described as a 15-item questionnaire being translated and validated.,,AI validation - Sonnet 4.5,0,0,,
56f8340e-1e83-4590-a6ef-397cbad0c5c6,Persian version of BoN,,,,,,,,,,,,PMID:37353850,,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,abstract,0.9,"The Persian version of the BoN is an acceptable tool in terms of structure and content, and it specifically assesses the practical aspects of daily activities for patients with neurofibromatosis.","This represents the translated/validated version of the questionnaire, which is the main output/tool of this study. Mining patterns may not have recognized this as a distinct tool.",,AI validation - Sonnet 4.5,0,0,,
8cbc58ad-f8e5-4679-b07f-66e2263c5a4d,WHOQOL-BREF,,,,,,,,,,,,PMID:37378983,,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,methods,1.0,"The 2 primary outcomes were the physical health and psychological QOL domain scores of the World Health Organization Quality of Life Brief Version (WHOQOL-BREF), recommended by the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.",This validated quality of life assessment tool was not captured despite being the primary outcome measure,,AI validation - Sonnet 4.5,0,0,,
3ec65b8f-631a-47f3-96d6-e7897008c12f,Perceived Stress Scale,,,,,,,,,,,,PMID:37378983,,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,methods,1.0,Inclusion criteria were...and (6) Perceived Stress Scale score of 6 or higher.,This validated psychological assessment scale was not captured despite being used for participant screening,,AI validation - Sonnet 4.5,0,0,,
583a50d2-e0b7-4072-a142-efb0596be0a6,Measure of Current Status-A,,,,,,,,,,,,PMID:37440099,,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,abstract,0.95,"We measured resilience factors via the Measure of Current Status-A (adaptive coping), Cognitive and Affective Mindfulness Scale-Revised",Clinical assessment tool name not recognized by mining patterns - may need pattern for 'Measure of [Name]-[Version]' format,,AI validation - Sonnet 4.5,0,0,,
c4b8429b-8b70-419e-b379-eec576dc3f4c,Cognitive and Affective Mindfulness Scale-Revised,,,,,,,,,,,,PMID:37440099,,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,abstract,0.95,"Measure of Current Status-A (adaptive coping), Cognitive and Affective Mindfulness Scale-Revised (mindfulness), Gratitude Questionnaire-6",Long clinical assessment tool name with 'Scale-Revised' suffix not captured by current patterns,,AI validation - Sonnet 4.5,0,0,,
516f9cd5-11f9-47b6-bc72-e49f78a1c7da,Gratitude Questionnaire-6,,,,,,,,,,,,PMID:37440099,,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,abstract,0.95,"Cognitive and Affective Mindfulness Scale-Revised (mindfulness), Gratitude Questionnaire-6 (gratitude), Life Orientation Test",Questionnaire with number suffix (Questionnaire-6) not recognized by current patterns,,AI validation - Sonnet 4.5,0,0,,
7ef8a75d-8f8a-47bc-9aa3-235ec8d91989,Life Orientation Test Optimism Scale,,,,,,,,,,,,PMID:37440099,,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,abstract,0.95,"Gratitude Questionnaire-6 (gratitude), Life Orientation Test Optimism Scale (optimism), and Medical Outcomes Study Social Support Survey",Complex multi-word clinical assessment tool name not captured by current patterns,,AI validation - Sonnet 4.5,0,0,,
87c556fc-109e-4c7f-b1e4-5b16fbda3aa2,Medical Outcomes Study Social Support Survey,,,,,,,,,,,,PMID:37440099,,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,abstract,0.95,"Life Orientation Test Optimism Scale (optimism), and Medical Outcomes Study Social Support Survey (perceived social support) at baseline",Long clinical assessment tool name starting with 'Medical Outcomes Study' not recognized,,AI validation - Sonnet 4.5,0,0,,
6ebc8ccc-21bf-40b2-af0d-00eb7c35b7be,Vineland Adaptive Behaviour Scale (VABS-III),,,,,,,,,,,,PMID:37608248,,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,methods,0.95,"...parent-reported Adaptive Behaviour Composite (ABC) scores on the Vineland Adaptive Behaviour Scale (VABS-III) [44], performance on an adaptive auditory n-back task...",Clinical assessment tool with standard abbreviation and version number not detected,,AI validation - Sonnet 4.5,0,0,,
5cd1e55d-8bc8-495f-b7ac-3caa7aff3266,n-back task,,,,,,,,,,,,PMID:37608248,,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,methods,0.9,"...performance on an adaptive auditory n-back task [16], and performance on a non-adaptive visual n-back task [16] performed during EEG...","Working memory assessment tool, both adaptive and non-adaptive versions used",,AI validation - Sonnet 4.5,0,0,,
a2d6ba7b-61e8-4328-94ae-083214b06d80,Sky search attention,,,,,,,,,,,,PMID:37608248,,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,methods,0.85,"...poorer performance relative to typically developing controls on various cognitive measures, including measures of working memory (i.e. digit-span forward/backwards) and attention (Sky search attention, TEACh)...",Attention assessment tool mentioned as part of cognitive battery,,AI validation - Sonnet 4.5,0,0,,
8b58071d-80a6-49ab-b142-7e8f3ea7a760,TEACh,,,,,,,,,,,,PMID:37608248,,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,methods,0.85,"...and attention (Sky search attention, TEACh)...","Attention assessment tool, likely Test of Everyday Attention for Children",,AI validation - Sonnet 4.5,0,0,,
820d2b31-9d6b-4bf7-8288-932c816f1a5f,FACE-Q Craniofacial Module-Appearance Distress scale,,,,,,,,,,,,PMID:38140900,,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,abstract,0.98,"The FACE-Q Craniofacial Module-Appearance Distress scale was the top-rated measure for potential use in neurofibromatosis 1 clinical trials. Strengths of the measure included that it was rigorously developed, included individuals with neurofibromatosis 1 in the validation sample","This is a specific, named clinical assessment tool that is the main recommendation of the paper. It should have been detected as it's a validated patient-reported outcome measure.",,AI validation - Sonnet 4.5,0,0,,
e05fe645-a1c5-4a25-a40d-e098e9a8dda5,Patient-Reported Outcome Rating and Acceptance Tool for Endpoints,,,,,,,,,,,,PMID:38140900,,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,abstract,0.9,Our revised Patient-Reported Outcome Rating and Acceptance Tool for Endpoints then was used to evaluate each published patient-reported outcome measures in five domains,This is a specific evaluation tool used in the methodology to assess other patient-reported outcome measures. It's a named clinical assessment instrument.,,AI validation - Sonnet 4.5,0,0,,
35e19c89-8b15-432c-888c-12f3916790aa,Tinnitus Functional Index,,,,,,,,,,,,PMID:38321701,,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,abstract,1.0,The Tinnitus Functional Index was identified as the most highly rated measure for the assessment of tinnitus in populations with neurofibromatosis type 2,This is the primary recommended outcome measure from the study but wasn't captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
6c2fac19-ba1f-4383-96dc-8fd1dd614796,Client Oriented Scale of Improvement-Tinnitus,,,,,,,,,,,,PMID:38321701,,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,methods,0.95,One measure was excluded (i.e. the Client Oriented Scale of Improvement-Tinnitus) because while it would be very useful for clinical settings,Specific tinnitus assessment tool mentioned by name but not captured,,AI validation - Sonnet 4.5,0,0,,
913092ce-735e-49a0-a2f5-b51a93986822,Patient-Reported Outcomes Rating Acceptance Tool for Endpoints,,,,,,,,,,,,PMID:38321701,,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,methods,0.9,using the Patient-Reported Outcomes Rating Acceptance Tool for Endpoints (PRO-RATE) form described and published previously,"Evaluation tool used to assess other PROMs, has acronym PRO-RATE",,AI validation - Sonnet 4.5,0,0,,
e6d44b78-ee60-4ebd-ade3-dc8b6c7abeab,PRO-RATE,,,,,,,,,,,,PMID:38321701,,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,methods,0.85,The PRO-RATE form allowed for the numerical scoring and consequent comparison of the PROMs under evaluation,"Acronym form of the evaluation tool, commonly used abbreviation",,AI validation - Sonnet 4.5,0,0,,
918fb3cb-3919-4c4c-9218-2c5bbf6b5ecd,PlexiQoL,,,,,,,,,,,,PMID:38499890,,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",abstract,1.0,The PlexiQoL questionnaire is a disease-specific QoL measure for adults with NF1-associated plexiform neurofibromas. The aim of this study was to adapt and validate a Dutch version of the PlexiQoL,This is the primary clinical assessment tool being studied - a disease-specific quality of life questionnaire. Should have been detected as it's explicitly described as a 'patient-reported outcome measure' and 'questionnaire',,AI validation - Sonnet 4.5,0,0,,
75d75a0f-4086-46ec-bbad-13dc1f47dfaa,Nottingham Health Profile,,,,,,,,,,,,PMID:38499890,,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",abstract,0.95,The Nottingham Health Profile (NHP) questionnaire was used as comparator questionnaire to evaluate convergent validity,This is a well-established clinical assessment tool used as a comparator for validation. The abbreviation 'NHP' and explicit mention as 'questionnaire' should have triggered detection,,AI validation - Sonnet 4.5,0,0,,
b08c6ac4-870b-4e01-ac5b-49ada6e832e5,cNF-Skindex,,,,,,,,,,,,PMID:38811427,,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,abstract,0.98,The French cNF-Skindex is the first questionnaire to specifically assess cNF-related QoL in patients with NF1. We aimed to adapt and validate a Dutch version of the cNF-Skindex.,Clinical assessment tool name not recognized by mining patterns. May need specific pattern for disease-specific questionnaire naming conventions (disease abbreviation + instrument name).,,AI validation - Sonnet 4.5,0,0,,
dc45fb47-fbd5-4996-a8f2-0604a370a07e,Dutch cNF-Skindex,,,,,,,,,,,,PMID:38811427,,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,abstract,0.98,We aimed to adapt and validate a Dutch version of the cNF-Skindex...The Dutch cNF-Skindex demonstrated excellent feasibility and reliability,Localized version of clinical assessment tool not detected. Mining may not recognize language-specific adaptations of instruments.,,AI validation - Sonnet 4.5,0,0,,
5580cd87-ab8c-4e72-a38f-545c6e9bf8dc,EQ-5D-5L,,,,,,,,,,,,PMID:38811427,,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,abstract,0.99,"The EQ-5D-5L and SF-36 were used to evaluate convergent validity, using Spearman's rank correlation coefficients.",Standard quality of life instrument not detected. Mining patterns may not include this specific EuroQol instrument variant.,,AI validation - Sonnet 4.5,0,0,,
2b120fff-e29a-4d3d-b18c-29e0906047b8,SF-36,,,,,,,,,,,,PMID:38811427,,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,abstract,0.99,"The EQ-5D-5L and SF-36 were used to evaluate convergent validity, using Spearman's rank correlation coefficients.",Well-established quality of life instrument not detected. SF-36 is a widely used clinical assessment tool that should be in mining patterns.,,AI validation - Sonnet 4.5,0,0,,
be455673-819e-43d9-983a-ddc474c1527c,Teller acuity cards,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.9,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards while older children were tested with Lea or KM (Konstantin Moutakis) cards,Specific clinical assessment tool for measuring visual acuity in young children - should be detected as validated clinical instrument,,AI validation - Sonnet 4.5,0,0,,
befd5d2a-b540-4508-8c95-3d2f538cda29,Cardiff acuity cards,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.9,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards while older children were tested with Lea or KM (Konstantin Moutakis) cards,Specific clinical assessment tool for measuring visual acuity in young children - should be detected as validated clinical instrument,,AI validation - Sonnet 4.5,0,0,,
21d1dc5b-d379-45a4-8d50-8bd629ea1e79,Lea cards,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.9,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards while older children were tested with Lea or KM (Konstantin Moutakis) cards,Specific clinical assessment tool for measuring visual acuity in children - should be detected as validated clinical instrument,,AI validation - Sonnet 4.5,0,0,,
33be11f1-fed7-40c3-8902-f46c3a334918,KM cards,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.85,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards while older children were tested with Lea or KM (Konstantin Moutakis) cards,Specific clinical assessment tool (Konstantin Moutakis cards) for measuring visual acuity - should be detected as validated clinical instrument,,AI validation - Sonnet 4.5,0,0,,
c1abdbce-e75d-428f-a972-45a423f8fb86,World Health Organization Categories of Childhood VI scale,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.9,In children ≥4 years of age VA at initial visit was compared with World Health Organization Categories of Childhood VI scale for reference,Standardized clinical assessment scale for categorizing visual impairment - should be detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
5042e8b6-7ba5-4713-8f3d-dbe19088fc43,Cirrus HD-OCT,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.9,"Optical coherence tomography images were obtained using Cirrus HD-OCT device (Cirrus; Carl Zeiss Meditec, Dublin, CA, USA)",Clinical diagnostic/assessment device with specific model and manufacturer - should be detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
efc3f603-4703-47c7-99fe-45e7300a929a,visual field index,,,,,,,,,,,,PMID:38990917,,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,methods,0.85,"Outcome measures were VA in logMAR, visual field index (VFI), average thicknesses of the ganglion cell-inner plexiform layer (GC-IPL)",Standardized clinical outcome measure for visual field assessment - should be detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
d24f5d06-ae4c-4cb2-84dc-ec664d4272d7,Vectra-H1,,,,,,,,,,,,PMID:39225289,,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,methods,0.9,"Images of up to eight cNFs from each participant were captured and analysed using each 3D imaging system: Vectra H1 (Canfield Scientific Inc, Fairfield, NJ, USA)",3D imaging device used as standardized outcome measure for clinical assessment - should be captured as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
4e0f26a8-1292-48c9-8df7-cc74f2e653ca,LifeViz-Micro,,,,,,,,,,,,PMID:39225289,,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,methods,0.9,"Images of up to eight cNFs from each participant were captured and analysed using each 3D imaging system: Vectra H1 (Canfield Scientific Inc, Fairfield, NJ, USA), LifeViz Micro (QuantifiCare, Biot, France)",3D imaging device used as standardized outcome measure for clinical assessment - should be captured as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
2f78679d-dd44-4cd8-8e89-45f051fc1720,Hannover classification system,,,,,,,,,,,,PMID:39824854,,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,methods,0.85,...Tumor size was classified by the Hannover and Koos classification systems...,Standardized clinical classification system for tumor grading used in the study,,AI validation - Sonnet 4.5,0,0,,
17fc216c-682a-45b6-9915-e62245d4181e,Koos classification system,,,,,,,,,,,,PMID:39824854,,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,methods,0.85,...Tumor size was classified by the Hannover and Koos classification systems...,Standardized clinical classification system for tumor grading used in the study,,AI validation - Sonnet 4.5,0,0,,
263f9240-4099-46ee-97c6-b215467d9b22,RECIST guidelines,,,,,,,,,,,,PMID:39824854,,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,methods,0.8,"...the maximum linear (tumor) diameter (MLD) in axial and coronal (medial to lateral and caudal to rostral/cranial, in total four measurements per MRI) planes were measured according to the RECIST guidelines...",Standardized clinical guidelines for tumor measurement used as assessment methodology,,AI validation - Sonnet 4.5,0,0,,
8cb2c8d1-c7f6-43bc-88a0-c695d07199f1,DICE coefficient,,,,,,,,,,,,PMID:39966622,,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,abstract,0.9,"A proof-of-concept AI model achieved a mean DICE score of 0.76 (standard deviation 0.21). After the final testing stage, the model improved to a final mean DICE score of 0.88",Validation metric/assessment tool not recognized as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
5b1b2e19-e583-4ec7-96b9-593183e09c1b,T1 weighted MRI,,,,,,,,,,,,PMID:39966622,,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,methods,0.85,"All images used for the POC were T1 weighted, post-contrast MRI scans.",Medical imaging protocol/technique not recognized as assessment tool,,AI validation - Sonnet 4.5,0,0,,
2adf86d8-9048-45d8-85cc-f8f4f48cc332,Custom Sleep Disorder Questionnaire,,,,,,,,,,,,PMID:40299482,,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,methods,0.95,"For data collection, an anonymous questionnaire consisting of multiple-choice and open-ended questions was designed and administered to all patients recruited in the survey. The questions in the questionnaire were aimed at assessing the presence of one or more sleep disorders and, if disorders were present, an assessment of the frequency of their presentation.","Custom questionnaire development not detected by mining patterns - may need patterns for 'questionnaire was designed', 'questionnaire consisting of', or 'questionnaire aimed at assessing'",,AI validation - Sonnet 4.5,0,0,,
92c42f50-8fde-4aac-b90f-3c130813f56b,Apple Watch Ultra model 2,,,,,,,,,,,,PMID:40299482,,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,methods,0.9,An assessment of sleep parameters (including the total sleep duration; time in bed vs. time asleep; napping frequency and napping duration; sleep stages; heart rate and respiratory metrics; sleep onset and sleep efficiency; and sleep breathing disorders) with an Apple Watch Ultra model 2 (application: Sleep++) was performed in all the patients,Wearable device for clinical assessment not detected - may need patterns for specific device models used for patient monitoring/assessment,,AI validation - Sonnet 4.5,0,0,,
b0de01b7-e128-4e7c-8b84-ddf1fc1d81f1,Numeric Rating Scale-11,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,methods,0.9,also provided feedback about existing pain measures (Numeric Rating Scale-11 and Pain Interference Index) assessing these domains (cognitive debriefing),Established clinical assessment tool used as foundation for new instrument development was not captured,,AI validation - Sonnet 4.5,0,0,,
e113a044-6eb0-4450-a120-e2cacb675ce7,NRS-11,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,methods,0.9,"The self-report NRS-11 has been used in numerous studies, including as a primary outcome measure, to assess pain intensity. This reliable and valid measure has been recommended for use in clinical trials","Abbreviated form of Numeric Rating Scale-11, established pain assessment tool",,AI validation - Sonnet 4.5,0,0,,
342d4eda-032a-457f-933c-2ce9dc4139a0,Pain Interference Index,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,methods,0.9,also provided feedback about existing pain measures (Numeric Rating Scale-11 and Pain Interference Index) assessing these domains (cognitive debriefing),Established clinical assessment tool used as foundation for new instrument development was not captured,,AI validation - Sonnet 4.5,0,0,,
25b96ab1-8bb0-415a-b222-226b9a3e9890,PII,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,methods,0.9,The PII is a 6-item questionnaire developed to assess the extent to which pain interferes with six different aspects of daily functioning on a 7-point Likert-type scale,"Abbreviated form of Pain Interference Index, established pain interference assessment tool",,AI validation - Sonnet 4.5,0,0,,
f36898a3-80ce-49cd-b6c7-65cdcea502fb,PAINS-pNF,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,abstract,0.95,"the measures' instructions, items, and formatting were modified to create the PAin INtensity Scale for plexiform neurofibromas (PAINS-pNF)",Newly developed clinical assessment tool was not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
c4402a67-656c-4241-884f-21525d36dc0c,PII-pNF,,,,,,,,,,,,PMID:40304934,,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,abstract,0.95,and the Pain Interference Index for plexiform neurofibromas (PII-pNF) for administration on a mobile app or web-based platform,Newly developed clinical assessment tool was not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
dff5a05f-0919-4571-87e1-d1ba2bf9f47f,Visual analogue scale,,,,,,,,,,,,PMID:40437318,,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,methods,0.95,The inclusion criteria for the pain group were an average pain score of ≥ 3 on the visual analogue 0–10 scale over the previous 10 weeks.,Clinical pain assessment scale not detected by mining patterns - likely missing clinical assessment tool patterns,,AI validation - Sonnet 4.5,0,0,,
37588139-d0be-4ee0-b932-1555b448e599,Rex Gauge durometer,,,,,,,,,,,,PMID:40529476,,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,methods,0.95,One was the Rex Gauge durometer (REX) produced by Rex Gauge LLC...The REX is primarily used in manufacturing and is the international standard for determining the hardness of nonmetallic materials...The Rex Gauge durometer was the first instrument used to measure skin 'hardness',Physical measurement device used as clinical outcome measure - should be classified as clinical assessment tool for quantifying neurofibroma stiffness,,AI validation - Sonnet 4.5,0,0,,
ba6556c8-0bdc-4aec-b545-60efa87d1fff,Delfin SkinFibroMeter,,,,,,,,,,,,PMID:40529476,,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,methods,0.95,"the other was the SkinFibroMeter (DEFLIN) made by Delfin Technologies...The DEFLIN is designed and marketed as an instrument to specifically measure tissue induration, assessing 'tissue stiffness in quantitative units.'",Specialized medical device for measuring tissue stiffness - clear clinical assessment tool for quantifying patient outcomes,,AI validation - Sonnet 4.5,0,0,,
2a6812e7-7fa2-496b-9dac-5c8ed41d6356,3-chamber social preference task,,,,,,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,0.9,The 3-chamber SP task occurred over 2 days as described previously,Standardized behavioral assessment not recognized as clinical tool,,AI validation - Sonnet 4.5,0,0,,
22f8174a-4b39-40ea-b6f7-f6cd92a4cb54,Open field test,,,,,,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,0.9,"OF tests Based on methods described previously, mice were placed in the dark in an open chamber",Standard behavioral assessment not recognized,,AI validation - Sonnet 4.5,0,0,,
50d906bb-432c-40b9-827f-f1889a64a74a,Delay discounting task,,,,,,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,0.9,"DDT tests Based on methods described previously, mice were trained to identify which side of a T maze",Cognitive behavioral assessment not recognized,,AI validation - Sonnet 4.5,0,0,,
3def145f-1116-4781-9f77-0a9d85185c63,Cliff avoidance reaction test,,,,,,,,,,,,PMID:40590220,,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,methods,0.9,"CAR tests Based on previously described methods, a round, plastic platform",Motor behavioral assessment not recognized,,AI validation - Sonnet 4.5,0,0,,
7f294718-f1a4-4409-9e47-45a357ea94b6,Likert scale questionnaire,,,,,,,,,,,,PMID:40737523,,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,abstract,0.95,A Likert scale questionnaire was used to survey clinicians' levels of agreement with 25 statements related to 2D and 3D tumor analyses.,"Clinical assessment tools (questionnaires, surveys, scales) may not be captured by current mining patterns focused on lab tools",,AI validation - Sonnet 4.5,0,0,,
37249212-8c31-4e85-abbc-34e4a61245f1,25-statement questionnaire,,,,,,,,,,,,PMID:40737523,,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,methods,0.9,Surveys were conducted via Qualtrics and included 25 statements organized into eight categories...The survey questions were structured as a Likert scale questionnaire,Specific questionnaire instruments may not be recognized as research tools by current patterns,,AI validation - Sonnet 4.5,0,0,,
2f0418ac-e528-4561-98af-5b55848f6719,Medical Research Council scale,,,,,,,,,,,,PMID:40896930,,High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.,methods,0.9,"The motor function of 9 muscle groups (deltoid, biceps, triceps, wrist flexors and extensors, interossei, abductor pollicis brevis, ankle flexors, and extensors) was graded bilaterally using the Medical Research Council scale (MRC)","This is a validated clinical assessment tool for grading muscle strength, commonly abbreviated as MRC scale. It's a standardized instrument used in neurological examinations.",,AI validation - Sonnet 4.5,0,0,,
3da0ec6e-1fac-49e5-9e09-d6b936217254,Survey of Well-being of Young Children,,,,,,,,,,,,PMID:41468561,,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,abstract,0.9,...we used mixed-effects models to relate the resulting centile scores to developmental delay assessed with the Survey of Well-being of Young Children. RESULTS: Our data set contained...,"This is a specific named developmental assessment instrument used to evaluate developmental delay in young children. It was likely missed because it's a longer, descriptive name that may not match typical clinical assessment tool patterns.",,AI validation - Sonnet 4.5,0,0,,
c2e83db5-b38f-4a23-8361-7ee6a480a673,Centers for Disease Control (CDC) growth charts,,,,,,,,,,,,PMID:41468561,,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,abstract,0.85,...We compared head circumference normalized using Centers for Disease Control (CDC) growth charts between these groups over time. We constructed NF1-specific growth charts...,CDC growth charts are standardized clinical assessment tools used for normalizing growth measurements. May have been missed due to the parenthetical abbreviation format or not recognizing growth charts as assessment tools.,,AI validation - Sonnet 4.5,0,0,,
f582ed95-3020-44aa-84ef-f674613ece8c,habituation learning assay,,,,,,,,,,,,PMID:41582719,,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of Neurofibromatosis.,abstract,0.8,...evidence that Cxcr4 chemokine receptor signaling is a regulator of habituation learning and modulator of cAMP-PKA signaling...,Behavioral assessment method for cognitive function mentioned but not captured. May need patterns for behavioral testing paradigms.,,AI validation - Sonnet 4.5,0,0,,
62d0d225-8240-4df2-9325-d5b70aa12218,Brief Pain Inventory Short Form,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,"...responses to the Brief Pain Inventory Short Form (BPI-SF) [ 8 ], Patient Health Questionnaire (PHQ) [ 19 ]...",Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
ef68c37d-643f-4442-89a5-34c16f802814,BPI-SF,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,...a pain severity aggregate score of ≥3 on the BPI-SF [ 8 ] for pain experienced in the previous 2 weeks...,Abbreviated form of Brief Pain Inventory Short Form not captured,,AI validation - Sonnet 4.5,0,0,,
c8c85638-5fd5-41c5-8d39-e60ba9b29186,Patient Health Questionnaire,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,"...responses to the Brief Pain Inventory Short Form (BPI-SF) [ 8 ], Patient Health Questionnaire (PHQ) [ 19 ], Structured Clinical Interview...",Standard clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
5a831d7c-4dc3-4c41-b52d-d64a50f6079a,PHQ,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,...evidence of moderate to severe depression or anxiety on the PHQ or GAD-7...,Abbreviated form of Patient Health Questionnaire not captured,,AI validation - Sonnet 4.5,0,0,,
8fbcecbe-a4e0-430b-9266-a2924d2b25ec,PHQ-9,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,...The PHQ-9 and GAD-7 are copyrighted by Pfizer Inc. and are freely available for research and clinical use...,Specific version of PHQ not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
f3648dfd-ed00-46e5-a8a4-9a9143c0241d,Structured Clinical Interview for DSM Self Report version,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,"...Patient Health Questionnaire (PHQ) [ 19 ], Structured Clinical Interview for DSM Self Report version (SCID-SR) [ 20 ], and Generalized Anxiety Disorder...",Long clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
6c5e379b-ce6e-41c5-8fce-d0ea46b8638d,SCID-SR,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,...evidence of psychosis or schizophrenia on the SCID-SR [ 20 ]. Members of the research team...,Abbreviated form of Structured Clinical Interview not captured,,AI validation - Sonnet 4.5,0,0,,
40461f3d-1cfe-403a-9e71-0aa2893de714,Generalized Anxiety Disorder 7 Item version,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,"...Structured Clinical Interview for DSM Self Report version (SCID-SR) [ 20 ], and Generalized Anxiety Disorder 7 Item version (GAD-7) [ 21 ]...",Long clinical assessment tool name not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
30deb1ef-da30-48ea-8d8c-678331d4efd5,GAD-7,,,,,,,,,,,,PMID:41602242,,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,methods,0.98,"...evidence of moderate to severe depression or anxiety on the PHQ or GAD-7, or (2) evidence of psychosis...",Abbreviated form of Generalized Anxiety Disorder scale not captured,,AI validation - Sonnet 4.5,0,0,,
9b48dc1c-985c-4246-8c41-53d6d116fee0,DSM III spectrophotometer,,,,,,,,,,,,PMID:6203987,,Neurofibromatosis of von Recklinghausen: a quantitative study of the epidermal keratinocyte and melanocyte populations.,methods,0.9,"All colometric data were obtained using a narrowband spectrophotometer DSM III (Cortex Technology, Hadsund, Denmark). DSM III is a handheld instrument used for measurement of skin colour, including melanin.",This is a specialized clinical measurement instrument with vendor and model information that should have been detected,,AI validation - Sonnet 4.5,0,0,,
deb90add-bb09-4fad-a411-06636ff26f68,Sony DSC-H50 digital camera,,,,,,,,,,,,PMID:6203987,,Neurofibromatosis of von Recklinghausen: a quantitative study of the epidermal keratinocyte and melanocyte populations.,methods,0.8,"A digital camera was used to determine the number and distribution of CALMs. The whole body of participants was photographed with a digital camera (Sony, DSC-H50, San Diego, USA).",Specialized clinical documentation equipment with specific model and vendor information,,AI validation - Sonnet 4.5,0,0,,
af46d70a-d503-4c18-a567-ff99b5636c50,PedsQL™ NF1 Module,,,,,,,,,,,,PMID:28078640,,"Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods.",abstract,0.95,"...develop the items and support the content validity for the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 Module for children, adolescents and young adults...",This is the primary clinical assessment tool being developed in this study. The mining may have missed it due to the trademark symbol (™) or complex naming convention.,,AI validation - Sonnet 4.5,0,0,,
d313e0ad-1d27-4968-8df3-53be6eea92b6,Pediatric Quality of Life Inventory™,,,,,,,,,,,,PMID:28078640,,"Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods.",abstract,0.85,...develop the items and support the content validity for the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 Module...,This is the parent instrument framework. May have been missed due to trademark symbol or being seen as too generic.,,AI validation - Sonnet 4.5,0,0,,
4d245698-0d77-46c1-9993-af9421333c37,PedsQL™,,,,,,,,,,,,PMID:28078640,,"Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods.",abstract,0.9,"...Qualitative methods support the content validity for the PedsQL™ NF1 Module for children, adolescents and young adults...",This is the abbreviated form of the assessment tool. Mining patterns may not recognize abbreviated forms with trademark symbols.,,AI validation - Sonnet 4.5,0,0,,
f57ba590-1b02-4908-a048-b78bff7ee5cc,Pediatric Quality of Life Inventory™ (PedsQL™),,,,,,,,,,,,PMID:28198162,,"The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives.",abstract,0.95,Data were drawn from qualitative interviews conducted for a larger study aimed at developing the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 module.,The mining patterns likely missed this due to the trademark symbols (™) and the fact it's mentioned as being 'developed' rather than 'used'. The tool name includes special characters and is embedded in a complex sentence structure.,,AI validation - Sonnet 4.5,0,0,,
8c3dde2c-18b7-4d97-a53d-cd4f064eabed,PedsQL™ NF1 module,,,,,,,,,,,,PMID:28198162,,"The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives.",abstract,0.9,Data were drawn from qualitative interviews conducted for a larger study aimed at developing the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 module.,This is the disease-specific module of PedsQL being developed in this study. Mining patterns may not have recognized this as a distinct tool or may have been confused by the 'developing' context rather than 'using' context.,,AI validation - Sonnet 4.5,0,0,,
e92725c6-989a-4af7-aa0e-bad85b2b32a7,Semi-structured interview guide,,,,,,,,,,,,PMID:30298332,,Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.,methods,0.85,"A semi-structured interview guide was constructed by all the authors, comprising questions concerning everyday life experiences, anxieties, fears, and self-perceived health regarding the nerve tumour",Clinical assessment instrument development not captured by current mining patterns,,AI validation - Sonnet 4.5,0,0,,
515fbdbe-4cb4-44b6-98d3-1b5f4fc8e772,Patient-Reported Outcomes Measurement Information System,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,abstract,0.98,"...completed the Patient-Reported Outcomes Measurement Information System (including domains anxiety, depressive symptom, psychosocial stress experiences, fatigue, pain interference, meaning and purpose, positive affect, peer relationships, physical function-mobility)...",Full name not recognized as clinical assessment tool - may need pattern for 'Patient-Reported Outcomes Measurement Information System' or 'PROMIS',,AI validation - Sonnet 4.5,0,0,,
9ac0318c-e215-4b07-9806-0ef903c31431,PROMIS,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,abstract,0.98,"...completed the Patient-Reported Outcomes Measurement Information System (including domains anxiety, depressive symptom, psychosocial stress experiences, fatigue, pain interference, meaning and purpose, positive affect, peer relationships, physical function-mobility)...",Acronym PROMIS not explicitly mentioned but this is the standard abbreviation for Patient-Reported Outcomes Measurement Information System,,AI validation - Sonnet 4.5,0,0,,
93605f18-e958-4c60-a723-8dba2c43a010,Quality of Life in Neurological Disorders measurement system,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,abstract,0.98,...and Quality of Life in Neurological Disorders measurement system (stigma) via an online platform...,Full name not recognized - may need pattern for 'Quality of Life in Neurological Disorders' or 'Neuro-QoL',,AI validation - Sonnet 4.5,0,0,,
1315564c-b921-49e1-a7aa-5024d1581763,Neuro-QoL,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,methods,0.98,"...Children with epilepsy, pNF and MD (sample-1) completed the original 18-item Neuro-QoL Stigma...",Neuro-QoL acronym not detected - this is a well-established clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
a93c00c6-e661-4daa-9b27-6728e83c4724,Neuro-QoL Stigma,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,methods,0.95,"...Children with epilepsy, pNF and MD (sample-1) completed the original 18-item Neuro-QoL Stigma...",Specific subscale of Neuro-QoL not detected - pattern may need to include subscale names,,AI validation - Sonnet 4.5,0,0,,
002a0754-bd5c-45b1-9c9f-a10e397e883e,PPS,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,results,0.9,...All items fit the IRT model and were able to be calibrated together to form the PPS which consists of 18 core items...,Newly developed scale acronym (Pediatric Perceived Stigma) not detected - may need pattern for scale development context,,AI validation - Sonnet 4.5,0,0,,
7de7078e-c8c1-46a1-b426-7cb870986655,PPS-Skin,,,,,,,,,,,,PMID:30413310,,Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma.,results,0.9,...The PPS-Skin (18 cores items + 6 skin items) was developed by calibrating 6 skin items onto the common metric as the PPS...,Variant of newly developed scale not detected - pattern should catch scale variants,,AI validation - Sonnet 4.5,0,0,,
a3917af5-191f-4291-92d0-abb4cb0d18f3,PedsQL Neurofibromatosis Type 1 Module,,,,,,,,,,,,PMID:32847704,,Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1,abstract,0.95,"The Pain, Cognitive Functioning, and Pain Impact Scales from the PedsQL Neurofibromatosis Type 1 Module and the PedsQL 4.0 Generic Core Scales were completed",Specific validated clinical assessment tool mentioned in abstract but not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
b48f4076-a9f6-4c46-9e2f-3b2fa82efdcf,PedsQL 4.0 Generic Core Scales,,,,,,,,,,,,PMID:32847704,,Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1,abstract,0.95,the PedsQL Neurofibromatosis Type 1 Module and the PedsQL 4.0 Generic Core Scales were completed in a multi-site national study,Widely used validated quality of life assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
e807e615-8a6d-43f0-8bc7-dd81a77ca746,PedsQL Sickle Cell Disease Module,,,,,,,,,,,,PMID:32847704,,Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1,methods,0.9,"The Pain Scale from the PedsQL Sickle Cell Disease Module, General Fatigue Scale and Sleep Disturbance Item from the PedsQL Multidimensional Fatigue Scale",Disease-specific validated assessment tool mentioned in methods section,,AI validation - Sonnet 4.5,0,0,,
3c56e50c-fb63-41df-8437-9d467218068a,PedsQL Multidimensional Fatigue Scale,,,,,,,,,,,,PMID:32847704,,Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1,methods,0.9,"General Fatigue Scale and Sleep Disturbance Item from the PedsQL Multidimensional Fatigue Scale, and the PedsQL 4.0 Generic Core Scales",Validated fatigue assessment scale not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
41fcebf5-79c2-48de-b0d7-1bdf47c416fe,Pediatric Quality of Life Inventory (PedsQL) NF1 Module,,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.98,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Disease-specific quality of life module not recognized as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
e4594e7a-625a-440f-a011-0bf10229d466,PedsQL 4.0 Generic Core Scales,,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.98,the PedsQL 4.0 Generic Core Scales were completed in a multi-site national study by 305 patients,Generic quality of life scales not recognized as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
9432804c-52d6-477b-a533-1d610592de25,Speech Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
f8de33a0-2c92-4fb9-a097-6cea9e319dd7,Communication Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
c9400069-b7a8-4c60-bc62-50cdd2f891d3,Worry Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
98f90b62-0791-4d09-a7f2-6682d20e8ccc,Pain Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
d86ae0e6-aeae-4433-a7ff-dafd3faca3b6,Skin Itch Bother Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
07823826-452f-4b9d-8661-9839f65cdf78,Skin Sensations Scale (PedsQL NF1 Module),,,,,,,,,,,,PMID:31081992,,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1",abstract,0.9,"The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Life Inventory (PedsQL) NF1 Module",Individual subscale not recognized as separate assessment tool,,AI validation - Sonnet 4.5,0,0,,
2c025450-817e-4511-b89d-5931de766e81,PedsQL Neurofibromatosis Type 1 Module,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",abstract,1.0,The 104-item PedsQL NF1 Module and 23-item PedsQL Generic Core Scales were completed in a multi-site national study by 323 patients and 335 parents,This is the primary clinical assessment tool being validated in the study - a 104-item disease-specific quality of life questionnaire,,AI validation - Sonnet 4.5,0,0,,
45889b42-4675-48ad-8911-755f271a74db,PedsQL Generic Core Scales,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",abstract,1.0,The 104-item PedsQL NF1 Module and 23-item PedsQL Generic Core Scales were completed in a multi-site national study,This is a standardized 23-item generic quality of life assessment tool used as a comparison measure,,AI validation - Sonnet 4.5,0,0,,
3ad3741c-ee21-4c06-aaa4-f830369bd5a2,Pediatric Quality of Life Inventory,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",abstract,1.0,The objective of the present study was to report on the measurement properties of the Pediatric Quality of Life Inventory (PedsQL),This is the full name of the PedsQL assessment system - a validated pediatric quality of life measurement tool,,AI validation - Sonnet 4.5,0,0,,
0020de01-c615-4f97-8ef0-b3636402cd8b,BASC-2,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",results,1.0,Summary scores for all subscales were within normal limits except for the BASC-2-PRS Attention Problems,"Behavioral Assessment System for Children, Second Edition - a standardized behavioral and emotional assessment tool",,AI validation - Sonnet 4.5,0,0,,
556c7fe3-162a-4bcb-adc9-675fd29735f9,BASC-2-SRP,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",results,1.0,"Within the BASC-2-SRP subscales, the highest percentage of children falling in the AR and CS range was for Attention Problems",BASC-2 Self-Report of Personality - child self-report version of the behavioral assessment,,AI validation - Sonnet 4.5,0,0,,
43eac87b-320b-4eaf-a350-b61ff1964f61,BASC-2-PRS,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",results,1.0,"For BASC-2-PRS subscales, the highest percentage of children falling in the AR range was for Attention Problems",BASC-2 Parent Rating Scales - parent-report version of the behavioral assessment,,AI validation - Sonnet 4.5,0,0,,
781f0382-f5a3-46cd-8b22-a8372f038b7c,National Institutes of Health diagnostic criteria,,,,,,,,,,,,PMID:29273891,,"PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity",abstract,0.9,Patients were diagnosed with NF1 using the National Institutes of Health diagnostic criteria,Standardized diagnostic criteria used for NF1 diagnosis - a clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
0b33606f-756d-4018-b5b7-6a8a614e8f08,PedsQL™ Neurofibromatosis Type 1 Module,,,,,,,,,,,,PMID:30465317,,"Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1",abstract,0.95,"The Pain, Skin Itch Bother, Skin Sensations, and Cognitive Functioning Scales from the PedsQL™ Neurofibromatosis Type 1 Module and the PedsQL™ Generic Core Scales were completed in a multi-site national study by 323 patients and 335 parents.",Disease-specific quality of life assessment tool with trademark symbol may not have been recognized by mining patterns,,AI validation - Sonnet 4.5,0,0,,
dfe87d77-2ae2-446f-9d8c-04efba300f43,PedsQL™ Generic Core Scales,,,,,,,,,,,,PMID:30465317,,"Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1",abstract,0.95,"The Pain, Skin Itch Bother, Skin Sensations, and Cognitive Functioning Scales from the PedsQL™ Neurofibromatosis Type 1 Module and the PedsQL™ Generic Core Scales were completed in a multi-site national study by 323 patients and 335 parents.",Generic quality of life assessment tool with trademark symbol may not have been recognized by mining patterns,,AI validation - Sonnet 4.5,0,0,,
cb9a5fd5-4451-4213-a724-36aa93f06b59,BASC-2-SRP,,,,,,,,,,,,PMID:30465317,,"Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1",results,0.9,"Within the BASC-2-SRP subscales, the highest percentage of children falling in the AR and CS range was for Attention Problems (43%) and Sense of Inadequacy (11%), respectively","Abbreviated form of Behavioral Assessment System for Children, Second Edition - Self-Report may not have been recognized",,AI validation - Sonnet 4.5,0,0,,
26d0fdd1-17ae-4f9f-895b-466d55bfae29,BASC-2-PRS,,,,,,,,,,,,PMID:30465317,,"Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1",results,0.9,"For BASC-2-PRS subscales, the highest percentage of children falling in the AR range was for Attention Problems (31%) and Functional Communication (31%).","Abbreviated form of Behavioral Assessment System for Children, Second Edition - Parent Rating Scale may not have been recognized",,AI validation - Sonnet 4.5,0,0,,
e607e14b-fbf7-4b49-997b-3b5a98c6a034,Pediatric Quality of Life Inventory,,,,,,,,,,,,PMID:30465317,,"Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1",results,0.85,PedsQL = Pediatric Quality of Life Inventory,Full name of PedsQL mentioned in table abbreviations may not have been captured,,AI validation - Sonnet 4.5,0,0,,
3a7a0702-8667-4f70-840d-13becfad5991,logMAR,,,,,,,,,,,,PMID:32642741,,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations,results,0.85,Of 24 patients with normal visual acuity (logMAR < 0.2 compared to age-based norms),Standard clinical visual acuity assessment tool used to measure outcomes,,AI validation - Sonnet 4.5,0,0,,
c6401f55-42fa-412a-b8eb-697cfb2596ee,Brief Symptom Inventory 18 (BSI-18),,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.95,Emotional and behavioral problems were measured using the Brief Symptom Inventory 18 (BSI-18) for adult respondents,Clinical assessment tool not detected - specific validated psychological assessment instrument,,AI validation - Sonnet 4.5,0,0,,
01782016-f7b1-4f0d-856e-570976a1e1d5,Behavior Problem Index (BPI),,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.95,Emotional and behavioral problems were measured using the Brief Symptom Inventory 18 (BSI-18) for adult respondents and the Behavior Problem Index (BPI) for adolescents,Clinical assessment tool not detected - validated behavioral assessment scale for adolescents,,AI validation - Sonnet 4.5,0,0,,
7e5b08ba-edd5-40bf-aba0-b5a2e6b8c88a,CCSS Neurocognitive Questionnaire,,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.95,"Neurocognitive outcomes were assessed for adult respondents with the CCSS Neurocognitive Questionnaire, which includes subscales measuring task efficiency, emotional regulation, organization, and memory",Clinical assessment tool not detected - validated neurocognitive assessment instrument developed for cancer survivors,,AI validation - Sonnet 4.5,0,0,,
df85755f-43ad-4529-a1f3-40e3a07158b1,Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0),,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.9,"Chronic health conditions were classified and severity-graded according to the Common Terminology Criteria for Adverse Events, version 4.0 (CTCAE v4.0)",Clinical assessment tool not detected - standardized classification system for adverse events,,AI validation - Sonnet 4.5,0,0,,
585f46c6-4bc3-4ace-9a33-7750626268bc,Activities of Daily Living (ADL),,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.85,"Activities of daily living (ADL, including eating, bathing, dressing or getting around the home) and instrumental activities of daily living (IADL, including household chores, necessary business, shopping or getting around for other purposes) were self-reported",Clinical assessment tool not detected - functional assessment scale,,AI validation - Sonnet 4.5,0,0,,
10387784-4d7d-4311-91e6-dafceb174994,Instrumental Activities of Daily Living (IADL),,,,,,,,,,,,PMID:32572180,,Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study,methods,0.85,"Activities of daily living (ADL, including eating, bathing, dressing or getting around the home) and instrumental activities of daily living (IADL, including household chores, necessary business, shopping or getting around for other purposes) were self-reported",Clinical assessment tool not detected - functional assessment scale for complex daily activities,,AI validation - Sonnet 4.5,0,0,,
da6f9cbd-ef15-40cd-9bed-71ac5b281ffe,Dermatology Life Quality Index,,,,,,,,,,,,PMID:31038470,,Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1,methods,0.95,...The Dermatology Life Quality Index was given to subjects before and after the procedure as surrogate for patient satisfaction...,"This is a well-established, validated dermatology-specific quality of life questionnaire (DLQI) that should have been detected as a clinical assessment tool. It's explicitly mentioned as being administered to patients before and after the procedure.",,AI validation - Sonnet 4.5,0,0,,
a77a3434-ae3b-45be-9d2b-043d3ba8d6be,SF-36,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.95,SF-36 is a QoL survey to assess general physical and emotional health. Skindex is an instrument to measure the effect of skin disease on QoL,Standard abbreviation for Short Form-36 quality of life questionnaire not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
441dd92a-e36b-4d49-bf2f-8f7529c5880c,Short Form-36,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.95,2 PRO instruments have been studied extensively in patients with cutaneous manifestations of NF1: Short Form (SF)–36 and Skindex,Full name of SF-36 questionnaire with hyphenated format not captured,,AI validation - Sonnet 4.5,0,0,,
1b60e537-03d0-492c-a0ea-2daf57c48861,Skindex,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.95,"Skindex is an instrument to measure the effect of skin disease on QoL, and has been validated for several dermatologic conditions including psoriasis and atopic dermatitis",Dermatology-specific quality of life instrument name not in mining patterns,,AI validation - Sonnet 4.5,0,0,,
c4ababfc-ffba-449a-a45b-8197ab0a377d,Investigator Global Assessment,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"an ordinal global assessment scale, such as the Investigator Global Assessment or the Physician Global Assessment, should be considered for the study of cNF in NF1",Clinical assessment scale name not captured by current patterns,,AI validation - Sonnet 4.5,0,0,,
241af5bf-9874-47cb-8d00-e7f83f3738f5,Physician Global Assessment,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"an ordinal global assessment scale, such as the Investigator Global Assessment or the Physician Global Assessment, should be considered for the study of cNF in NF1",Clinical assessment scale name not captured by current patterns,,AI validation - Sonnet 4.5,0,0,,
fed6a76c-a118-4fd4-a908-5bb769897879,paper frame,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.85,The paper frame is a clinician-reported outcome measure used to quantify the number of cNF lesions (figure 2). A 100 cm2 paper frame is placed on the skin and all cNF lesions within the frame are counted,Physical measurement tool for clinical assessment not captured,,AI validation - Sonnet 4.5,0,0,,
c4171d61-2f35-48f4-805a-836eb39c0e70,optical coherence tomography,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"New approaches, such as optical coherence tomography (OCT) or high-frequency ultrasound (HFUS), may assess the full thickness of a lesion above and below the skin surface",Imaging-based clinical assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
1f6b7020-4d0c-4886-98bf-3c951c0e6a95,OCT,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"New approaches, such as optical coherence tomography (OCT) or high-frequency ultrasound (HFUS), may assess the full thickness of a lesion above and below the skin surface",Abbreviation for optical coherence tomography not captured,,AI validation - Sonnet 4.5,0,0,,
9b53d934-6048-404a-a609-552c66325ce8,high-frequency ultrasound,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"New approaches, such as optical coherence tomography (OCT) or high-frequency ultrasound (HFUS), may assess the full thickness of a lesion above and below the skin surface",Imaging-based clinical assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
93ec3efa-1be8-4fcf-9825-c97e877afcb3,HFUS,,,,,,,,,,,,PMID:29987133,,Clinical trial design for cutaneous neurofibromas,results,0.9,"New approaches, such as optical coherence tomography (OCT) or high-frequency ultrasound (HFUS), may assess the full thickness of a lesion above and below the skin surface",Abbreviation for high-frequency ultrasound not captured,,AI validation - Sonnet 4.5,0,0,,
794b7cf1-9db6-43d4-a7fb-ea2bd76d7f64,REiNS cNF Working Group Survey,,,,,,,,,,,,PMID:34230202,,Perspective of Adults With Neurofibromatosis type 1 and Cutaneous Neurofibromas,methods,0.85,An online survey developed by multidisciplinary experts and patient representatives of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) cNF Working Group was distributed to adults with NF1,The survey instrument itself is a clinical assessment tool but may not have been recognized due to lack of standardized naming or formal validation status,,AI validation - Sonnet 4.5,0,0,,
09317a66-e486-4307-90b6-3d4f23c64147,Rex Gauge durometer,,,,,,,,,,,,PMID:34230197,,Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.,methods,0.95,One was the Rex Gauge durometer (REX) produced by Rex Gauge LLC...The REX is primarily used in manufacturing and is the international standard for determining the hardness of nonmetallic materials,Specific brand name and model of clinical measurement device not caught by mining patterns,,AI validation - Sonnet 4.5,0,0,,
689ae55b-f4b5-4b36-8951-26839d902afd,Delfin SkinFibroMeter,,,,,,,,,,,,PMID:34230197,,Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.,methods,0.95,the other was the SkinFibroMeter (DEFLIN) made by Delfin Technologies...The DEFLIN is designed and marketed as an instrument to specifically measure tissue induration,Specific brand name and model of clinical measurement device not caught by mining patterns,,AI validation - Sonnet 4.5,0,0,,
534e8ea9-9688-4181-a9fe-2a3b873e13e1,high-frequency ultrasound,,,,,,,,,,,,PMID:34230197,,Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.,abstract,0.85,"digital calipers, 3D photography, and high-frequency ultrasound (HFUS) for measurement of cutaneous neurofibromas",Medical imaging technique for measurement not caught by clinical assessment patterns,,AI validation - Sonnet 4.5,0,0,,
015dabcc-b833-4898-bd1e-47a19ff54844,n-back task,,,,,,,,,,,,PMID:36316421,,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1,methods,0.9,Both verbal and visuospatial working memory were assessed using the n-back task. The task was programmed in-house using E-Prime software,Standardized cognitive assessment task for working memory - clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
07ad1095-fbe4-4c7f-b1c2-709c6a91ce3a,Vineland Adaptive Behaviour Scale,,,,,,,,,,,,PMID:36316421,,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1,methods,0.95,Parent-rated Vineland Adaptive Behaviour Scale—third edition was administered to the parents to assess child adaptive behaviour,Standardized clinical assessment scale with edition specified - clear clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
9f0f6222-84ae-43cf-a844-3a8f5aa9ccb1,Conners 3 rating scale,,,,,,,,,,,,PMID:36316421,,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1,methods,0.95,Conners 3 rating scale was used as a standardized measure for parent reported ADHD symptoms. It consists of 27 items each rated on a 4-point Likert scale,Standardized ADHD assessment scale with detailed description - clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
43106c05-24c9-4eb8-a1bd-4da1dcae4b1b,Corsi block task,,,,,,,,,,,,PMID:36316421,,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1,methods,0.9,participants were asked to complete the computerised Corsi block task on the Psychology Experiment Building Language (PEBL),Standardized visuospatial working memory assessment task - clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
391d43bf-ef04-4f70-9539-7149c37d5fe1,Kowa AP7000 Precise Perimeter,,,,,,,,,,,,PMID:28587872,,Validation of an automated tractography method for the optic radiations as a biomarker of visual acuity in neurofibromatosis-associated optic pathway glioma.,methods,0.9,"Patients had a visual field examination both prior to surgery and 1 month following correction of refractive defects, utilizing the Kowa AP7000 Precise Perimeter from Kowa, Japan.",Clinical assessment device with specific model number was not caught by mining patterns,,AI validation - Sonnet 4.5,0,0,,
3a86bdbf-2bce-4d6a-b560-b09a54347dd5,EEG,,,,,,,,,,,,PMID:35648241,,Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.,results,0.9,Routine awake EEG revealed focal epileptiform discharges...A 24-h EEG captured three electroclinical seizures...A recent 24-h EEG captured no electrographic or clinical seizures,EEG is a standard clinical assessment tool for epilepsy evaluation but may not have been recognized as a research tool,,AI validation - Sonnet 4.5,0,0,,
995a6a71-81c8-47fa-87c9-e73d5101352e,24-hour EEG monitoring,,,,,,,,,,,,PMID:35648241,,Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.,results,0.85,A 24-h EEG captured three electroclinical seizures that lateralized to the right hemisphere but were poorly localized,Extended EEG monitoring is a specialized clinical assessment tool for seizure characterization,,AI validation - Sonnet 4.5,0,0,,
8139cd8a-62a3-45d6-acc4-1bdce425f61d,Neurological examination,,,,,,,,,,,,PMID:35648241,,Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.,results,0.75,"Physical examination was notable for café-au-lait macules, axillary freckling, and left-sided facial weakness...Examination was notable for dysarthria, left lower facial weakness",Standardized neurological examination is a clinical assessment tool for evaluating neurological function,,AI validation - Sonnet 4.5,0,0,,
4295da4d-7a65-45b9-b58e-f7f89ea00020,n-back task,,,,,,,,,,,,PMID:35673329,,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,methods,0.95,Verbal and visuospatial working memory was assessed using the n-back task. The task was programmed in-house using E-Prime software.,"This is a well-established cognitive assessment tool for working memory, but may have been missed due to hyphenated format or lack of specific clinical assessment patterns",,AI validation - Sonnet 4.5,0,0,,
e34d67ce-2b6c-4318-8f30-cfdab6f2cd18,Corsi block task,,,,,,,,,,,,PMID:35673329,,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,methods,0.95,Memory span was assessed using a computerized Corsi block task on the Psychology Experiment Building Language (PEBL),"Standard neuropsychological assessment tool, may have been missed due to lack of clinical assessment patterns",,AI validation - Sonnet 4.5,0,0,,
b2fa094b-d7b5-4ed2-8099-8decffe2294f,WISC-IV,,,,,,,,,,,,PMID:35673329,,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,methods,0.95,Auditory working memory was assessed using the digit span forward and back task of the Wechslers Intelligence Scale for Children-Fourth edition (WISC-IV,"Standard clinical assessment tool, may lack specific patterns for psychological test batteries",,AI validation - Sonnet 4.5,0,0,,
d35aea3d-96ef-482d-b52b-48006fbbe256,Vineland Adaptive Behavior Scale,,,,,,,,,,,,PMID:35673329,,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,methods,0.95,Parent-rated Vineland Adaptive Behavior Scale—third edition (Hill et al. 2017) was administered to the parents to assess child adaptive behavior,"Clinical assessment scale, may lack patterns for parent-report measures",,AI validation - Sonnet 4.5,0,0,,
06f80122-0ae8-4aa4-b5b3-bb1b4703a10f,Conners 3 rating scale,,,,,,,,,,,,PMID:35673329,,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,methods,0.95,Conners 3 rating scale(Conners et al. 2011) was used as a standardized measure for parent reported ADHD symptoms,"ADHD rating scale, may lack patterns for behavioral rating scales",,AI validation - Sonnet 4.5,0,0,,
c3f7c957-f4fa-4849-ba9c-9c4c75599b72,ICD-10,,,,,,,,,,,,PMID:36565307,,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",methods,0.9,"a strong positive COVID-19 diagnostic code from the International Classification of Diseases, 10th Revision (ICD-10) or Systematized Nomenclature of Medicine (SNOMED) tables",Clinical diagnostic coding system used for patient classification,,AI validation - Sonnet 4.5,0,0,,
b101b3c2-0e8e-4e03-8a0e-78ffec866321,SNOMED,,,,,,,,,,,,PMID:36565307,,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",methods,0.9,"a strong positive COVID-19 diagnostic code from the International Classification of Diseases, 10th Revision (ICD-10) or Systematized Nomenclature of Medicine (SNOMED) tables",Clinical terminology system used for medical coding,,AI validation - Sonnet 4.5,0,0,,
0aed01fd-e19a-403d-af66-bf9f3cec3502,WHO COVID-19 Severity Scale,,,,,,,,,,,,PMID:36565307,,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",results,0.85,"We first identified the patients in the previously examined disease cohorts with highest documented severity (N3C severity type severe, ie, World Health Organization severity 7-9 and mortality/hospice, ie, World Health Organization severity 10)",Clinical assessment tool for COVID-19 severity scoring,,AI validation - Sonnet 4.5,0,0,,
f5e3de28-46e6-43f8-b1fa-0f610c3b10be,N3C COVID-19 Phenotype,,,,,,,,,,,,PMID:36565307,,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",methods,0.8,The N3C cohort and case definition criteria are publicly available as described in version 3.3 of the N3C COVID-19 phenotype documentation,Standardized clinical phenotyping tool for COVID-19 case definition,,AI validation - Sonnet 4.5,0,0,,
f337723c-31af-421d-b62a-afc565411902,Pain intensity scale (0-10),,,,,,,,,,,,PMID:32187457 ,,Selumetinib in Children with Inoperable Plexiform Neurofibromas,abstract,0.95,Children rated tumor pain intensity on a scale from 0 (no pain) to 10 (worst pain imaginable).,Mining patterns may not recognize numerical rating scale descriptions or pain assessment terminology,,AI validation - Sonnet 4.5,0,0,,
3190ea85-e7fe-4de7-abdb-687a59645b6b,Numeric Rating Scale-11,,,,,,,,,,,,PMID:37115514,,Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas,methods,0.95,Phase 2 participants completed patient-reported outcome measures assessing tumor pain intensity (Numeric Rating Scale-11) and interference of pain in daily life,Clinical assessment tool not captured by current mining patterns - specific pain scale with numerical identifier,,AI validation - Sonnet 4.5,0,0,,
2ab9f704-b0d6-4342-8dac-31eeabb6d692,pain interference index,,,,,,,,,,,,PMID:37115514,,Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas,methods,0.9,Phase 2 participants completed patient-reported outcome measures assessing tumor pain intensity (Numeric Rating Scale-11) and interference of pain in daily life (pain interference index),Clinical assessment tool not captured - pain interference measurement instrument,,AI validation - Sonnet 4.5,0,0,,
36890a9a-d778-480e-ac52-1a1a850489d2,National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.95,Adverse events (AE) were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0.,Full formal name of standardized toxicity grading system not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
fff717cb-7636-4547-af61-dd0f86e403bc,NCI CTCAE v4.0,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.9,Adverse events (AE) were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0.,Common abbreviation for toxicity grading system not recognized,,AI validation - Sonnet 4.5,0,0,,
02594c8c-95d8-4f45-a4f5-5e9bf97b63f6,Lansky performance status,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.9,Exclusion criteria included Lansky or Karnofsky performance statuses of less than 60,Pediatric performance status scale not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
f4a4f328-3fcd-4e88-8ea1-faa6fb17d608,Karnofsky performance status,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.9,Exclusion criteria included Lansky or Karnofsky performance statuses of less than 60,Adult performance status scale not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
5b7d5452-b901-46ed-8ab9-db2298fc8e3a,polysomnography,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.85,"For patients with tumors affecting the airway, video laryngoscopy, polysomnography, and pulmonary function tests (if age appropriate) were obtained",Sleep study assessment tool not recognized by mining patterns,,AI validation - Sonnet 4.5,0,0,,
c3c8d09c-728d-42be-aae7-4050a59f5e37,video laryngoscopy,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.8,"For patients with tumors affecting the airway, video laryngoscopy, polysomnography, and pulmonary function tests (if age appropriate) were obtained",Airway assessment procedure not recognized by mining patterns,,AI validation - Sonnet 4.5,0,0,,
5b67a27f-50d2-49cb-94f5-b9ebe81b4d82,apnea-hypopnea index,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.85,The primary sleep endpoint evaluated on polysomnography was the apnea–hypopnea index. A clinically meaningful improvement was defined as an absolute decrease in AHI by ≥5 events per hour.,Sleep study outcome measure (AHI) not captured by mining patterns,,AI validation - Sonnet 4.5,0,0,,
51f7bdcf-56ec-472e-816d-668eb13eb702,REiNS sleep and pulmonary outcomes recommendations,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,methods,0.9,Analysis of functional responses for the cohort of participants with airway involvement were guided by the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) sleep and pulmonary outcomes recommendations,Disease-specific outcome guidelines not recognized by mining patterns,,AI validation - Sonnet 4.5,0,0,,
9cef138b-1db3-4f4c-8ee8-83345bea7e04,impulse oscillometry,,,,,,,,,,,,PMID:37174087,,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study,discussion,0.8,"Of note, impulse oscillometry was not routinely assessed clinically for the participants and was not required as part of the trial.",Pulmonary function assessment tool mentioned in discussion not captured,,AI validation - Sonnet 4.5,0,0,,
2dc2df2e-e956-4a74-a7ca-4f6e0b294b35,KBIT-2,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Kaufman Brief Intelligence Test– Second Edition (KBIT-2) [46]. The KBIT-2 is a brief measure of cognitive abilities including verbal reasoning and nonverbal reasoning.,Clinical assessment tool not recognized - standardized cognitive assessment instrument,,AI validation - Sonnet 4.5,0,0,,
d7770428-c19d-4c16-a449-15ada4cc7937,Kaufman Brief Intelligence Test-Second Edition,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Kaufman Brief Intelligence Test– Second Edition (KBIT-2) [46]. The KBIT-2 is a brief measure of cognitive abilities,Full name of cognitive assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
cf5fa29a-ae1c-4c84-a6e6-269040abcb8f,WIAT-III,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Wechsler Individual Achievement Test– Third Edition (WIAT-III) Word Reading subtest [47]. The WIAT-III is a measure used to assess academic functioning,Academic achievement assessment tool not recognized,,AI validation - Sonnet 4.5,0,0,,
df500a1c-1cea-42a3-aa1c-d23c2159052f,Wechsler Individual Achievement Test-Third Edition,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Wechsler Individual Achievement Test– Third Edition (WIAT-III) Word Reading subtest [47],Full name of academic assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
5fb1306d-49d4-4227-b0be-017f1866d342,KSADS-ADHD,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version– Attention Deficit/Hyperactivity Disorder module (KSADS-ADHD),Psychiatric assessment interview tool not recognized,,AI validation - Sonnet 4.5,0,0,,
964e003b-27d9-4535-88a9-39d1e42f5650,Schedule for Affective Disorders and Schizophrenia for School-Age Children,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version– Attention Deficit/Hyperactivity Disorder module,Full name of psychiatric assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
2f27c72a-9db9-47e9-a8a8-f5184fa3c92f,SCQ,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Communication Questionnaire (SCQ) [49]. The SCQ is a caregiver-report questionnaire that examines ASD symptomatology,Autism screening questionnaire not recognized,,AI validation - Sonnet 4.5,0,0,,
49bb33fa-8542-47f2-8da6-ac5851a06927,Social Communication Questionnaire,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Communication Questionnaire (SCQ) [49]. The SCQ is a caregiver-report questionnaire that examines ASD symptomatology,Full name of autism screening tool not captured,,AI validation - Sonnet 4.5,0,0,,
d5925817-931e-4e56-90ff-9551e3728d5a,SSIS-SEL,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Skills Improvement System Social-Emotional Learning (SSIS-SEL) [52]. The SSIS-SEL is a caregiver and self-report questionnaire measure examining social-emotional skills,Social skills assessment questionnaire not recognized,,AI validation - Sonnet 4.5,0,0,,
d20ccdb5-1221-4139-b477-52185aa4d364,Social Skills Improvement System Social-Emotional Learning,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Skills Improvement System Social-Emotional Learning (SSIS-SEL) [52]. The SSIS-SEL is a caregiver and self-report questionnaire measure,Full name of social skills assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
a7228d02-691e-4923-83c6-f7f0a9701f21,SRS-2,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Responsiveness Scale– Second Edition (SRS-2) [57]. The SRS-2 is a caregiver-report questionnaire of social impairment and repetitive behavior,Social responsiveness assessment scale not recognized,,AI validation - Sonnet 4.5,0,0,,
5d9f7dbc-9135-4120-bab0-0cbcba13e6a0,Social Responsiveness Scale-Second Edition,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Social Responsiveness Scale– Second Edition (SRS-2) [57]. The SRS-2 is a caregiver-report questionnaire of social impairment,Full name of social responsiveness scale not captured,,AI validation - Sonnet 4.5,0,0,,
2b79cb27-47f7-4595-8559-d95d24183347,FQS,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,"Friendship Qualities Scale (FQS) [58]. The FQS is a self-report questionnaire examining the friendship qualities of companionship, conflict, help, security and closeness",Friendship assessment questionnaire not recognized,,AI validation - Sonnet 4.5,0,0,,
af604afd-73cc-494b-8976-8493af5095ed,Friendship Qualities Scale,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Friendship Qualities Scale (FQS) [58]. The FQS is a self-report questionnaire examining the friendship qualities,Full name of friendship assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
69ccd6c0-90e7-438b-91da-5ba2f271543c,QSQ,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Quality of Socialization Questionnaire (QSQ) [59]. The QSQ is a caregiver and self-report questionnaire to gather information about the adolescent's get-togethers with peers,Socialization assessment questionnaire not recognized,,AI validation - Sonnet 4.5,0,0,,
c18f3994-cdc8-47f2-8087-f05caca2becb,Quality of Socialization Questionnaire,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Quality of Socialization Questionnaire (QSQ) [59]. The QSQ is a caregiver and self-report questionnaire to gather information,Full name of socialization assessment tool not captured,,AI validation - Sonnet 4.5,0,0,,
3864aef5-44ef-4900-8e4f-1989138ca0c0,TASSK,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Test of Adolescent Social Skills Knowledge (TASSK) [33]. The TASSK is a self-report 30-item questionnaire that measures knowledge of specific social skills,Social skills knowledge assessment tool not recognized,,AI validation - Sonnet 4.5,0,0,,
478d7e43-86bd-4cd2-a553-6f1c840549db,Test of Adolescent Social Skills Knowledge,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.95,Test of Adolescent Social Skills Knowledge (TASSK) [33]. The TASSK is a self-report 30-item questionnaire that measures knowledge,Full name of social skills knowledge test not captured,,AI validation - Sonnet 4.5,0,0,,
ea07b9d7-d77b-4c31-af27-17fb02bb9a84,PEERS,,,,,,,,,,,,PMID: 38475852,,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1,methods,0.9,The PEERS® intervention was administered by certified PEERS® providers when possible or by well-trained graduate students,PEERS intervention protocol/curriculum is a structured clinical intervention tool,,AI validation - Sonnet 4.5,0,0,,
cb4c7b10-6d84-4e69-ac69-88f926d6b1d3,Skindex,,,,,,,,,,,,PMID:39196570,,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1,abstract,0.95,"MAIN OUTCOMES AND MEASURES: Total Skindex scores and subdomain scores (symptoms, emotion, function, pain, and itch).","The mining patterns may not have recognized 'Skindex' as a clinical assessment tool, or may have missed it due to lack of explicit keywords like 'questionnaire' or 'scale'",,AI validation - Sonnet 4.5,0,0,,
249c428f-80cf-4e70-9501-a6dee3ab0083,cNF-Skindex,,,,,,,,,,,,PMID:37149083,,cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.,abstract,0.98,"The cNF-Skindex, validated in a French population, specifically assesses the cNF-related QOL...we validated the score and the strata in a United States population",This is the primary clinical assessment tool being validated in the study - should have been detected as a quality of life questionnaire,,AI validation - Sonnet 4.5,0,0,,
8ec57816-592f-42cb-8ae5-1899a30eaad6,EQ-5D-5L,,,,,,,,,,,,PMID:37149083,,cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.,methods,0.95,The EQ-5D-5L and SF-36 were used to evaluate convergent validity...The EQ-5D-5L is a brief and generic health status measure that comprises five dimensions,Well-known validated health status questionnaire used for convergent validity - should be detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
2119a1f7-6b52-4efe-92de-81e5cc81ef59,SF-36,,,,,,,,,,,,PMID:37149083,,cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.,methods,0.95,The EQ-5D-5L and SF-36 were used to evaluate convergent validity...The 36-item Short Form Survey (SF-36) is a generic health-related QoL measure,Widely used validated quality of life questionnaire - should be detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
344f3db3-9f58-4821-9d6c-bb5b4a309275,Life Events Checklist (LEC),,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.95,"Participants completed the Life Events Checklist, adapted from Elliott-DeSorbo et al. [ 30 ], to document stressful events in the past three months. The score is the number of stressful events endorsed (range 0–22).",Specific validated questionnaire name with scoring range - should have been detected as clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
0172c11f-17b8-4af7-b276-6bfd54f76a95,Rating of Overall Stress Scale (ROSS),,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.9,Participants rated their stress in the past month from 0 (not stressed) to 10 (very stressed). This measure was adapted from Leidy et al. [ 31 ].,Named stress assessment scale with clear scoring system - should have been detected,,AI validation - Sonnet 4.5,0,0,,
4177a442-0356-4c74-8f29-559fa05bf436,PROMIS depression,,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.95,"The following PROMIS self-report short forms were administered: depression (8 items) [ 32 ], pain interference (6 items) [ 33 ], and cognitive function (8 items) [ 34 ].",PROMIS is a well-known validated patient-reported outcome measure system,,AI validation - Sonnet 4.5,0,0,,
e9619a96-943a-4636-adc5-28529855b82f,PROMIS pain interference,,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.95,"The following PROMIS self-report short forms were administered: depression (8 items) [ 32 ], pain interference (6 items) [ 33 ], and cognitive function (8 items) [ 34 ].",PROMIS pain interference is a validated clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
ebd2d670-b5c7-42a2-bda9-c93b24ebc452,PROMIS cognitive function,,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.95,"The following PROMIS self-report short forms were administered: depression (8 items) [ 32 ], pain interference (6 items) [ 33 ], and cognitive function (8 items) [ 34 ].",PROMIS cognitive function is a validated clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
e292b7db-e285-4194-8d5a-548d77c1726d,Barriers to Adherence Questionnaire,,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.85,The barriers to adherence measure was created by the study team; participants were asked to think of times they missed a dose of their study drug in the past month and marked which of 16 possible reasons caused them to miss a dose.,Custom questionnaire developed for adherence assessment - valid clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
df2eb416-a8eb-4d48-be31-e5b31bd1fbb1,MEMS™ (Medication Events Monitoring System),,,,,,,,,,,,PMID:39858077,,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,methods,0.9,"Participants' study drug bottles were fitted with a MEMS™ cap at baseline. Having been given instructions to take the drug 12 h apart, adherence was defined as opening the bottle 11–13 h since their last dose.",Technology-based medication adherence monitoring system - clinical assessment tool,,AI validation - Sonnet 4.5,0,0,,
